100 results on '"Marie-Pierre Bousquet"'
Search Results
2. Des recherches sans factures : dépenser ses fonds et gérer les relations avec le service des finances
- Author
-
Marie-Pierre Bousquet
- Subjects
conduite responsable ,intégrité ,administration ,finances ,Ethics ,BJ1-1725 - Abstract
En matière de gestion des finances, il n’est pas toujours facile, pour les chercheurs, de suivre les normes strictes suivies par les institutions. Mais un chercheur « délinquant » aux yeux du système est-il forcément non éthique?
- Published
- 2024
- Full Text
- View/download PDF
3. Druggable redox pathways against Mycobacterium abscessus in cystic fibrosis patient-derived airway organoids.
- Author
-
Stephen Adonai Leon-Icaza, Salimata Bagayoko, Romain Vergé, Nino Iakobachvili, Chloé Ferrand, Talip Aydogan, Célia Bernard, Angelique Sanchez Dafun, Marlène Murris-Espin, Julien Mazières, Pierre Jean Bordignon, Serge Mazères, Pascale Bernes-Lasserre, Victoria Ramé, Jean-Michel Lagarde, Julien Marcoux, Marie-Pierre Bousquet, Christian Chalut, Christophe Guilhot, Hans Clevers, Peter J Peters, Virginie Molle, Geanncarlo Lugo-Villarino, Kaymeuang Cam, Laurence Berry, Etienne Meunier, and Céline Cougoule
- Subjects
Immunologic diseases. Allergy ,RC581-607 ,Biology (General) ,QH301-705.5 - Abstract
Mycobacterium abscessus (Mabs) drives life-shortening mortality in cystic fibrosis (CF) patients, primarily because of its resistance to chemotherapeutic agents. To date, our knowledge on the host and bacterial determinants driving Mabs pathology in CF patient lung remains rudimentary. Here, we used human airway organoids (AOs) microinjected with smooth (S) or rough (R-)Mabs to evaluate bacteria fitness, host responses to infection, and new treatment efficacy. We show that S Mabs formed biofilm, and R Mabs formed cord serpentines and displayed a higher virulence. While Mabs infection triggers enhanced oxidative stress, pharmacological activation of antioxidant pathways resulted in better control of Mabs growth and reduced virulence. Genetic and pharmacological inhibition of the CFTR is associated with better growth and higher virulence of S and R Mabs. Finally, pharmacological activation of antioxidant pathways inhibited Mabs growth, at least in part through the quinone oxidoreductase NQO1, and improved efficacy in combination with cefoxitin, a first line antibiotic. In conclusion, we have established AOs as a suitable human system to decipher mechanisms of CF-driven respiratory infection by Mabs and propose boosting of the NRF2-NQO1 axis as a potential host-directed strategy to improve Mabs infection control.
- Published
- 2023
- Full Text
- View/download PDF
4. Pharmacologic Normalization of Pancreatic Cancer-Associated Fibroblast Secretome Impairs Prometastatic Cross-Talk With MacrophagesSummary
- Author
-
Rémi Samain, Alexia Brunel, Thibault Douché, Marjorie Fanjul, Stéphanie Cassant-Sourdy, Julia Rochotte, Jérôme Cros, Cindy Neuzillet, Jérôme Raffenne, Camille Duluc, Aurélie Perraud, Jérémy Nigri, Véronique Gigoux, Ivan Bieche, Matteo Ponzo, Gilles Carpentier, Ilaria Cascone, Richard Tomasini, Herbert A. Schmid, Muriel Mathonnet, Rémy Nicolle, Marie-Pierre Bousquet, Yvan Martineau, Stéphane Pyronnet, Christine Jean, and Corinne Bousquet
- Subjects
Antimetastatic Therapy ,Cancer-Associated Fibroblasts ,Pancreatic Adenocarcinoma ,Stromal Cell Cross-Talk ,Stroma Normalization ,Macrophages ,Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
Background & Aims: Cancer-associated fibroblasts (CAFs) from pancreatic adenocarcinoma (PDA) present high protein synthesis rates. CAFs express the G-protein–coupled somatostatin receptor sst1. The sst1 agonist SOM230 blocks CAF protumoral features in vitro and in immunocompromised mice. We have explored here the therapeutic potential of SOM230, and underlying mechanisms, in immunocompetent models of murine PDA mimicking the heavy fibrotic and immunosuppressive stroma observed in patient tumors. Methods: Large-scale mass spectrometry analyses were performed on media conditioned from 9 patient PDA-derived CAF primary cultures. Spontaneous transgenic and experimental (orthotopic co-graft of tumor cells plus CAFs) PDA-bearing mice were longitudinally ultrasound-monitored for tumor and metastatic progression. Histopathology and flow cytometry analyses were performed on primary tumors and metastases. Stromal signatures were functionally validated through bioinformatics using several published, and 1 original, PDA database. Results: Proteomics on the CAF secretome showed that SOM230 controls stromal activities including inflammatory responses. Among the identified secreted proteins, we validated that colony-stimulating factor 1 (CSF-1) (a macrophage growth factor) was reduced by SOM230 in the tumor and plasma of PDA-harboring mice, alongside intratumor stromal normalization (reduced CAF and macrophage activities), and dramatic metastasis reduction. In transgenic mice, these SOM230 benefits alleviate the chemotherapy-induced (gemcitabine) immunosuppressive stroma reshaping. Mechanistically, SOM230 acts in vivo on CAFs through sst1 to disrupt prometastatic CAF production of CSF-1 and cross-talk with macrophages. We found that in patients, stromal CSF-1 was associated with aggressive PDA forms. Conclusions: We propose SOM230 as an antimetastatic therapy in PDA for its capacity to remodel the fibrotic and immunosuppressive myeloid stroma. This pharmacotherapy should benefit PDA patients treated with chemotherapies.
- Published
- 2021
- Full Text
- View/download PDF
5. Conformational maps of human 20S proteasomes reveal PA28- and immuno-dependent inter-ring crosstalks
- Author
-
Jean Lesne, Marie Locard-Paulet, Julien Parra, Dušan Zivković, Thomas Menneteau, Marie-Pierre Bousquet, Odile Burlet-Schiltz, and Julien Marcoux
- Subjects
Science - Abstract
Immune cells express immunoproteasomes (i20S), which bind to specialized regulators, contain different catalytic subunits and generate immunogenic peptides. HDX-MS—based assessment of the differences between the conformational dynamics of standard and i20s reveals specific, allosteric changes in i20S and upon regulator binding.
- Published
- 2020
- Full Text
- View/download PDF
6. Establishing 20S Proteasome Genetic, Translational and Post-Translational Status from Precious Biological and Patient Samples with Top-Down MS
- Author
-
Angelique Sanchez Dafun, Dušan Živković, Stephen Adonai Leon-Icaza, Sophie Möller, Carine Froment, Delphine Bonnet, Adriana Almeida de Jesus, Laurent Alric, Muriel Quaranta-Nicaise, Audrey Ferrand, Céline Cougoule, Etienne Meunier, Odile Burlet-Schiltz, Frédéric Ebstein, Raphaela Goldbach-Mansky, Elke Krüger, Marie-Pierre Bousquet, and Julien Marcoux
- Subjects
immunoproteasome ,PRAAS ,proteasome ,proteoform ,top-down proteomics ,label-free quantification ,Cytology ,QH573-671 - Abstract
The mammalian 20S catalytic core of the proteasome is made of 14 different subunits (α1-7 and β1-7) but exists as different subtypes depending on the cell type. In immune cells, for instance, constitutive catalytic proteasome subunits can be replaced by the so-called immuno-catalytic subunits, giving rise to the immunoproteasome. Proteasome activity is also altered by post-translational modifications (PTMs) and by genetic variants. Immunochemical methods are commonly used to investigate these PTMs whereby protein-tagging is necessary to monitor their effect on 20S assembly. Here, we present a new miniaturized workflow combining top-down and bottom-up mass spectrometry of immunopurified 20S proteasomes that analyze the proteasome assembly status as well as the full proteoform footprint, revealing PTMs, mutations, single nucleotide polymorphisms (SNPs) and induction of immune-subunits in different biological samples, including organoids, biopsies and B-lymphoblastoid cell lines derived from patients with proteasome-associated autoinflammatory syndromes (PRAAS). We emphasize the benefits of using top-down mass spectrometry in preserving the endogenous conformation of protein modifications, while enabling a rapid turnaround (1 h run) and ensuring high sensitivity (1–2 pmol) and demonstrate its capacity to semi-quantify constitutive and immune proteasome subunits.
- Published
- 2023
- Full Text
- View/download PDF
7. Introduction : Autochtones et épidémies : vides et profusion
- Author
-
Marie-Pierre Bousquet
- Subjects
Anthropology ,GN1-890 ,History (General) ,D1-2009 - Published
- 2022
- Full Text
- View/download PDF
8. Mémoires d’épidémies : faire face à la maladie dans les récits anicinapek
- Author
-
Marie-Pierre Bousquet, Maurice J. Kistabish, John Mowatt, and Laurence Hamel-Charest
- Subjects
épidémies ,Anicinapek ,système de santé ,prévention ,soins ,valeurs ,epidemics ,health system ,prevention ,care ,values ,epidemias ,sistema de salud ,prevención ,cuidados ,valores ,Anthropology ,GN1-890 ,History (General) ,D1-2009 - Abstract
Depuis les années 1800, les Anicinapek ont connu diverses épidémies qui ont laissé des traces dans leur mémoire et leurs pratiques, ravivées lors du confinement du printemps 2020. Ces traces diffèrent de celles laissées dans les chroniques des auteurs allochtones : les autorités gouvernementales et ecclésiastiques les ont pensés sans ressources, sans savoirs et sans médicaments efficaces. Dans une perspective de décolonisation des savoirs, nous remettons en question l’hégémonie du discours allochtone sur les épidémies historiques chez les Autochtones en explorant comment les Anicinapek ont conceptualisé la notion d’épidémies, ainsi que les pratiques qu’ils pouvaient déployer face à elles. Cet article se fonde en priorité sur un corpus de données formé à partir de deux types de sources : des récits oraux recueillis lors d’enquêtes longitudinales ; et des documents écrits par des Anicinapek. À partir de cet angle émique, sont exposées les assises idéologiques et cosmologiques du système de santé anicinape, de la moitié du xixe siècle jusqu’aux années 1970.
- Published
- 2022
- Full Text
- View/download PDF
9. Faire de la recherche en ethnologie/ethnolinguistique dans un contexte totalitaire : les défis d’étudier des sujets sensibles
- Author
-
Marie-Pierre Bousquet
- Subjects
anthropologie ,risques ,sujets sensibles ,ethnologie ,ethnolinguistique ,Ethics ,BJ1-1725 - Abstract
La recherche ethnologique et ethnolinguistique peut poser un large éventail de défis éthiques différents pour les chercheurs et les communautés dans lesquelles ils travaillent. Les ethnologues et les ethnolinguistes étudient les sociétés humaines sous différents angles pour comprendre leurs caractères culturels, leurs variabilités linguistiques, etc. Ces recherches peuvent faire progresser la compréhension que l’on a des groupes sociaux et contribuer à la production de connaissances, et peuvent même parfois être bénéfiques pour certaines communautés. Mais elle peut aussi créer des risques pour les participants et les communautés (par exemple perte de la vie privée, stigmatisation, persécution), et pour les chercheurs eux-mêmes (par exemple perte d'accès à une zone de terrain, perte de contrôle du processus et des résultats de la recherche). Ces risques et autres défis éthiques, ainsi que les moyens d'y faire face, méritent une attention particulière de la part des ethnologues et de l'ethnolinguistique.
- Published
- 2020
- Full Text
- View/download PDF
10. The intermediate proteasome is constitutively expressed in pancreatic beta cells and upregulated by stimulatory, low concentrations of interleukin 1 β.
- Author
-
Muhammad Saad Khilji, Danielle Verstappen, Tina Dahlby, Michala Cecilie Burstein Prause, Celina Pihl, Sophie Emilie Bresson, Tenna Holgersen Bryde, Phillip Alexander Keller Andersen, Kristian Klindt, Dusan Zivkovic, Marie-Pierre Bousquet-Dubouch, Björn Tyrberg, Thomas Mandrup-Poulsen, and Michal Tomasz Marzec
- Subjects
Medicine ,Science - Abstract
A central and still open question regarding the pathogenesis of autoimmune diseases, such as type 1 diabetes, concerns the processes that underlie the generation of MHC-presented autoantigenic epitopes that become targets of autoimmune attack. Proteasomal degradation is a key step in processing of proteins for MHC class I presentation. Different types of proteasomes can be expressed in cells dictating the repertoire of peptides presented by the MHC class I complex. Of particular interest for type 1 diabetes is the proteasomal configuration of pancreatic β cells, as this might facilitate autoantigen presentation by β cells and thereby their T-cell mediated destruction. Here we investigated whether so-called inducible subunits of the proteasome are constitutively expressed in β cells, regulated by inflammatory signals and participate in the formation of active intermediate or immuno-proteasomes. We show that inducible proteasomal subunits are constitutively expressed in human and rodent islets and an insulin-secreting cell-line. Moreover, the β5i subunit is incorporated into active intermediate proteasomes that are bound to 19S or 11S regulatory particles. Finally, inducible subunit expression along with increase in total proteasome activities are further upregulated by low concentrations of IL-1β stimulating proinsulin biosynthesis. These findings suggest that the β cell proteasomal repertoire is more diverse than assumed previously and may be highly responsive to a local inflammatory islet environment.
- Published
- 2020
- Full Text
- View/download PDF
11. Les recherches-action ou collaboratives sont-elles plus éthiques? Réflexions d’une ethnologue en milieu autochtone canadien
- Author
-
Marie-Pierre Bousquet
- Subjects
recherches-action ,recherches collaboratives ,éthique ,autochtones ,ethnologie ,Canada ,Ethics ,BJ1-1725 - Abstract
Au Canada, depuis le début des années 2000, les recherches-action et collaboratives sont devenues de plus en plus populaires dans les sciences sociales. Dans ces recherches, les connaissances sont produites non pas seulement par les chercheurs spécialisés, mais avec les acteurs de terrain. Elles sont souvent présentées comme la panacée en matière d’éthique vis-à-vis des populations locales, surtout quand celles-ci sont en situation de marginalisation. Ces recherches sont en effet vues comme une voie d’empowerment possible. J’examine ici la façon dont ces types de recherches, appliquées à des disciplines non normatives comme la mienne, peuvent en changer le visage, à partir de mon expérience d’anthropologue en milieu amérindien au Québec. Sont-elles vraiment plus éthiques que les recherches fondamentales? Je montre les questionnements soulevés par ces modèles, qui peuvent changer les façons de pratiquer mon métier, en prêtant une attention particulière à l’engagement du chercheur, à la validité et la solidité des méthodologies et des épistémologies, ainsi qu’aux degrés de participation des informateurs, tout cela dans le cadre des règles éthiques formulées par les conseils subventionnaires canadiens et par les Autochtones eux-mêmes.
- Published
- 2019
- Full Text
- View/download PDF
12. Top-Down and Intact Protein Mass Spectrometry Data Visualization for Proteoform Analysis Using VisioProt-MS
- Author
-
Jean Lesne, Marie-Pierre Bousquet, Julien Marcoux, and Marie Locard-Paulet
- Subjects
Biology (General) ,QH301-705.5 - Abstract
The rise of intact protein analysis by mass spectrometry (MS) was accompanied by an increasing need for flexible tools allowing data visualization and analysis. These include inspection of the deconvoluted molecular weights of the proteoforms eluted alongside liquid chromatography (LC) through their representation in three-dimensional (3D) liquid chromatography coupled to mass spectrometry (LC-MS) maps (plots of deconvoluted molecular weights, retention times, and intensity of the MS signal). With this aim, we developed a free and open-source web application named VisioProt-MS ( https://masstools.ipbs.fr/mstools/visioprot-ms/ ). VisioProt-MS is highly compatible with many algorithms and software developed by the community to integrate and deconvolute top-down and intact protein MS data. Its dynamic and user-friendly features greatly facilitate analysis through several graphical representations dedicated to MS and tandem mass spectrometry (MS/MS) analysis of proteoforms in complex samples. Here, we will illustrate the importance of LC-MS map visualization to optimize top-down acquisition/search parameters and analyze intact protein MS data. We will go through the main features of VisioProt-MS using the human proteasomal 20S core particle as a user-case.
- Published
- 2019
- Full Text
- View/download PDF
13. Au-delà de la bureaucratie obligatoire : comment bien travailler avec des comités d’éthique de la recherche
- Author
-
Marie-Pierre Bousquet and Bryn Williams-Jones
- Subjects
éthique de la recherche ,CÉR ,université ,vision négative ,mandat ,chercheur ,Ethics ,BJ1-1725 - Abstract
Les comités d’éthique de la recherche (CÉR) universitaire, même s’ils sont bien établis en Amérique du nord depuis les années 1980, ont encore parfois mauvaise réputation au sein des chercheurs. Parfois, ils sont vus par les membres de la communauté scientifique comme un système bureaucratique voué à empêcher ou à ralentir la recherche et ne comprenant pas la réalité des chercheurs. Cette vision négative relève souvent de la mécompréhension 1) de la part des chercheurs et 2) de certains CÉR de ce qu’est le mandat d’un CÉR et de la façon dont il doit fonctionner. Fondée sur une expérience d’une présidente d’un CÉR et d’un bioéthicien, cette foire aux questions vise à démystifier l’éthique de la recherche pour que les chercheurs et les CÉR puissent collaborer dans l’avancement des connaissances, tout en assurant une conduite de recherche éthique et responsable.
- Published
- 2018
- Full Text
- View/download PDF
14. Pharmacological targeting of the protein synthesis mTOR/4E‐BP1 pathway in cancer‐associated fibroblasts abrogates pancreatic tumour chemoresistance
- Author
-
Camille Duluc, Siham Moatassim‐Billah, Mounira Chalabi‐Dchar, Aurélie Perraud, Rémi Samain, Florence Breibach, Marion Gayral, Pierre Cordelier, Marie‐Bernadette Delisle, Marie‐Pierre Bousquet‐Dubouch, Richard Tomasini, Herbert Schmid, Muriel Mathonnet, Stéphane Pyronnet, Yvan Martineau, and Corinne Bousquet
- Subjects
cancer‐associated fibroblasts ,chemoresistance ,pancreatic cancer ,pharmacotherapy ,protein synthesis and secretion ,Medicine (General) ,R5-920 ,Genetics ,QH426-470 - Abstract
Abstract Pancreatic ductal adenocarcinoma (PDAC) is extremely stroma‐rich. Cancer‐associated fibroblasts (CAFs) secrete proteins that activate survival and promote chemoresistance of cancer cells. Our results demonstrate that CAF secretome‐triggered chemoresistance is abolished upon inhibition of the protein synthesis mTOR/4E‐BP1 regulatory pathway which we found highly activated in primary cultures of α‐SMA‐positive CAFs, isolated from human PDAC resections. CAFs selectively express the sst1 somatostatin receptor. The SOM230 analogue (Pasireotide) activates the sst1 receptor and inhibits the mTOR/4E‐BP1 pathway and the resultant synthesis of secreted proteins including IL‐6. Consequently, tumour growth and chemoresistance in nude mice xenografted with pancreatic cancer cells and CAFs, or with pieces of resected human PDACs, are reduced when chemotherapy (gemcitabine) is combined with SOM230 treatment. While gemcitabine alone has marginal effects, SOM230 is permissive to gemcitabine‐induced cancer cell apoptosis and acts as an antifibrotic agent. We propose that selective inhibition of CAF protein synthesis with sst1‐directed pharmacological compounds represents an anti‐stromal‐targeted therapy with promising chemosensitization potential.
- Published
- 2015
- Full Text
- View/download PDF
15. Deciphering preferential interactions within supramolecular protein complexes: the proteasome case
- Author
-
Bertrand Fabre, Thomas Lambour, Luc Garrigues, François Amalric, Nathalie Vigneron, Thomas Menneteau, Alexandre Stella, Bernard Monsarrat, Benoît Van den Eynde, Odile Burlet‐Schiltz, and Marie‐Pierre Bousquet‐Dubouch
- Subjects
affinity purification ,correlation profiling ,label‐free quantitative proteomics ,mass spectrometry ,Biology (General) ,QH301-705.5 ,Medicine (General) ,R5-920 - Abstract
Abstract In eukaryotic cells, intracellular protein breakdown is mainly performed by the ubiquitin–proteasome system. Proteasomes are supramolecular protein complexes formed by the association of multiple sub‐complexes and interacting proteins. Therefore, they exhibit a very high heterogeneity whose function is still not well understood. Here, using a newly developed method based on the combination of affinity purification and protein correlation profiling associated with high‐resolution mass spectrometry, we comprehensively characterized proteasome heterogeneity and identified previously unknown preferential associations within proteasome sub‐complexes. In particular, we showed for the first time that the two main proteasome subtypes, standard proteasome and immunoproteasome, interact with a different subset of important regulators. This trend was observed in very diverse human cell types and was confirmed by changing the relative proportions of both 20S proteasome forms using interferon‐γ. The new method developed here constitutes an innovative and powerful strategy that could be broadly applied for unraveling the dynamic and heterogeneous nature of other biologically relevant supramolecular protein complexes.
- Published
- 2015
- Full Text
- View/download PDF
16. Comparison of label-free quantification methods for the determination of protein complexes subunits stoichiometry
- Author
-
Bertrand Fabre, Thomas Lambour, David Bouyssié, Thomas Menneteau, Bernard Monsarrat, Odile Burlet-Schiltz, and Marie-Pierre Bousquet-Dubouch
- Subjects
26S proteasome ,Affinity purification mass spectrometry (AP-MS) ,iBAQ ,Top3 ,Spectral counting ,Genetics ,QH426-470 - Abstract
Protein complexes are the main molecular machines that support all major cellular pathways and their in-depth characterization are essential to understand their functions. Determining the stoichiometry of the different subunits of a protein complex still remains challenging. Recently, many label-free quantitative proteomic approaches have been developed to study the composition of protein complexes. It is therefore of great interest to evaluate these different methods in a stoichiometry oriented objective. Here we compare the ability of four absolute quantitative label-free methods currently used in proteomic studies to determine the stoichiometry of a well-characterized protein complex, the 26S proteasome.
- Published
- 2014
- Full Text
- View/download PDF
17. Supplementary Figures from Phosphoproteomics Identifies PI3K Inhibitor–selective Adaptive Responses in Pancreatic Cancer Cell Therapy and Resistance
- Author
-
Julie Guillermet-Guibert, Maximilian Reichert, Benoît Thibault, Anne Gomez-Brouchet, Emilio Hirsch, Odile Burlet-Schiltz, Paola Cappello, Barbara Garmy-Susini, Camille Guyon, Fernanda Ramos-Delgado, Frédéric Pont, Nicole Therville, Coralie Cayron, Marie-Pierre Bousquet, Emmanuelle Mouton-Barbosa, Zahra Dantes, Thibault Douche, and Célia Cintas
- Abstract
Supplementary Figures file contains merged Figure S1 to S8 including description of cell lines, Human samples, PI3K inhibitor stability, SILAC setup and controls, STRING analysis, quantifications of WB and cellular assays, prediction of kinase motifs found regulated, effects of combination of treatment in vitro, correlation between cell survival and phosphopeptide intensity, effects of combination treatment in Human samples and in vivo.
- Published
- 2023
- Full Text
- View/download PDF
18. Supplementary Table 1 from Phosphoproteomics Identifies PI3K Inhibitor–selective Adaptive Responses in Pancreatic Cancer Cell Therapy and Resistance
- Author
-
Julie Guillermet-Guibert, Maximilian Reichert, Benoît Thibault, Anne Gomez-Brouchet, Emilio Hirsch, Odile Burlet-Schiltz, Paola Cappello, Barbara Garmy-Susini, Camille Guyon, Fernanda Ramos-Delgado, Frédéric Pont, Nicole Therville, Coralie Cayron, Marie-Pierre Bousquet, Emmanuelle Mouton-Barbosa, Zahra Dantes, Thibault Douche, and Célia Cintas
- Abstract
Supplementary Table 1 contains the list of files deposited on PRIDE Proteome X Change under the number PXD008410.
- Published
- 2023
- Full Text
- View/download PDF
19. Supplementary Methods from Phosphoproteomics Identifies PI3K Inhibitor–selective Adaptive Responses in Pancreatic Cancer Cell Therapy and Resistance
- Author
-
Julie Guillermet-Guibert, Maximilian Reichert, Benoît Thibault, Anne Gomez-Brouchet, Emilio Hirsch, Odile Burlet-Schiltz, Paola Cappello, Barbara Garmy-Susini, Camille Guyon, Fernanda Ramos-Delgado, Frédéric Pont, Nicole Therville, Coralie Cayron, Marie-Pierre Bousquet, Emmanuelle Mouton-Barbosa, Zahra Dantes, Thibault Douche, and Célia Cintas
- Abstract
This file contains the additional information for Material and method, including method for cell transduction, cell treatment and WB, RT-qPCR analysis, viablity assays, proliferation assays, DEVD cleavage assay, flow cytometry, soft agar assay, organoid and soft agar assay quantification and ImageJ plugin, scriot for analaysis of unpaired heavy/light phosphopeptides, method for SILAC labelling, SILAC sample preparation, data-dependent acquisition LC-MS/MS, phosphoproteomic data analysis, mice housing, details on statistics, as well as Legends of supplementary figures and tables, table with sequences of shRNAs, used antibodies, RT-qPCR primers.
- Published
- 2023
- Full Text
- View/download PDF
20. Supplementary Table 3 from Phosphoproteomics Identifies PI3K Inhibitor–selective Adaptive Responses in Pancreatic Cancer Cell Therapy and Resistance
- Author
-
Julie Guillermet-Guibert, Maximilian Reichert, Benoît Thibault, Anne Gomez-Brouchet, Emilio Hirsch, Odile Burlet-Schiltz, Paola Cappello, Barbara Garmy-Susini, Camille Guyon, Fernanda Ramos-Delgado, Frédéric Pont, Nicole Therville, Coralie Cayron, Marie-Pierre Bousquet, Emmanuelle Mouton-Barbosa, Zahra Dantes, Thibault Douche, and Célia Cintas
- Abstract
Supplementary Table 3 contains the location of isoform selective phosphorylations in the protein.
- Published
- 2023
- Full Text
- View/download PDF
21. Supplementary Table 2 from Phosphoproteomics Identifies PI3K Inhibitor–selective Adaptive Responses in Pancreatic Cancer Cell Therapy and Resistance
- Author
-
Julie Guillermet-Guibert, Maximilian Reichert, Benoît Thibault, Anne Gomez-Brouchet, Emilio Hirsch, Odile Burlet-Schiltz, Paola Cappello, Barbara Garmy-Susini, Camille Guyon, Fernanda Ramos-Delgado, Frédéric Pont, Nicole Therville, Coralie Cayron, Marie-Pierre Bousquet, Emmanuelle Mouton-Barbosa, Zahra Dantes, Thibault Douche, and Célia Cintas
- Abstract
Supplementary Table 2 contains the list of isoform selective peptides in each condition, with quantification and global pathway analysis.
- Published
- 2023
- Full Text
- View/download PDF
22. Y avait-il des deux-esprits chez les Anicinabek ?
- Author
-
Laurence Hamel-Charest, Marie-Pierre Bousquet, and Anna Mapachee
- Subjects
Social Sciences and Humanities ,genres ,deux-esprits ,Anicinabek/Algonquin ,Anicinabek/Algonquinos ,dos espíritus ,valeurs ,sexos ,valores ,Automotive Engineering ,gender ,values ,Anicinabek/Algonquins ,sex ,Sciences Humaines et Sociales ,sexes ,two-spirit ,géneros - Abstract
Y avait-il des genres alternatifs chez les Anicinabek ? La question a émergé après qu’un centre de santé, désireux de lutter contre l’homophobie, eut voulu créer des outils culturellement adéquats, fondés sur la tradition anicinabe. En collaboration avec ce centre, les auteures ont effectué une recherche sur les sexes et les genres auprès de personnes reconnues comme porteuses de savoirs sur les temps anciens. S’aidant d’une revue de littérature sur les deux-esprits chez les Premières Nations en général, elles ont noté que rien en anicinabemowin ne traduit l’existence d’autres genres que homme/femme et d’autres pratiques qu’hétérosexuelles. La sexualité était un domaine caché et les gens étaient pudiques. L’importance de la discrétion, dans un contexte où la reproduction était capitale, a fait ressortir les valeurs qui sont fondamentales pour les Anicinabek, comme le respect et la non-ingérence. Ainsi, être un « bon homme » et une « bonne femme » semble plus important que les préférences amoureuses et sexuelles de chacun., Were there alternative genders among the Anicinabek? The question emerged after a health centre, wanting to fight homophobia, sought to develop culturally appropriate tools based on the Anicinabe tradition. In collaboration with this centre, we conducted a study on gender and sex with people who are recognized as bearers of traditional knowledge. With the help of a literature review on two-spiritedness among First Nations in general, we noted that nothing in Anicinabemowin shows the existence of genders other than male/female and practices other than heterosexual. Sexuality was a hidden domain and people were modest. The importance of discretion, in a context where reproduction was paramount, highlighted values that are fundamental to Anicinabek, such as respect and non-interference. Thus, being a “good man” and a “good woman” appears to be more important than one’s sexual or romantic preferences., ¿Existían géneros alternativos entre los Anicinabek? La cuestión surgió después de que un centro de salud, que deseaba luchar contra la homofobia, quisiera crear herramientas culturalmente apropiadas basadas en la tradición anicinabe. En colaboración con este centro, las autoras llevaron a cabo una investigación sobre género y sexo con personas reconocidas como portadoras de conocimientos ancestrales. A partir de una revisión de la bibliografía sobre la dualidad de espíritus entre las Primeras Naciones en general, observaron que nada en anicinabemowin refleja la existencia de géneros distintos al masculino/femenino y de prácticas distintas a la heterosexual. La sexualidad era un área oculta y la gente era púdica. La importancia de la discreción, en un contexto en el que la reproducción era primordial, puso de manifiesto valores fundamentales para los Anicinabek, como el respeto y la no injerencia. Así, ser un “buen hombre” y una “buena mujer” parece ser más importante que las propias preferencias amorosas y sexuales.
- Published
- 2021
- Full Text
- View/download PDF
23. Extracellular 20S proteasome secreted via microvesicles can degrade poorly folded proteins and inhibit Galectin-3 agglutination activity
- Author
-
Anne Bonhoure, Laurent Henry, Claudia Bich, Lionel Blanc, Blanche Bergeret, Marie‐Pierre Bousquet, Olivier Coux, Pierre‐Emmanuel Stoebner, and Michel Vidal
- Subjects
Agglutination ,Cytoplasm ,Proteasome Endopeptidase Complex ,Structural Biology ,Galectin 3 ,Proteolysis ,Genetics ,Humans ,Cell Biology ,Molecular Biology ,Biochemistry - Abstract
Proteasomes are major non-lysosomal proteolytic complexes localized in the cytoplasm and in the nucleus of eukaryotic cells. Strikingly, high levels of extracellular proteasome have also been evidenced in the plasma (p-proteasome) of patients with specific diseases. Here, we examined the process by which proteasomes are secreted, as well as their structural and functional features once in the extracellular space. We demonstrate that assembled 20S core particles are secreted by cells within microvesicles budding from the plasma membrane. Part of the extracellular proteasome pool is also free of membranes in the supernatant of cultured cells, and likely originates from microvesicles leakage. We further demonstrate that this free proteasome released by cells (cc-proteasome for cell culture proteasome) possesses latent proteolytic activity and can degrade various extracellular proteins. Both standard (no immune-subunits) and intermediate (containing some immune-subunits) forms of 20S are observed. Moreover, we show that galectin-3, which displays a highly disordered N-terminal region, is efficiently cleaved by purified cc-proteasome, without SDS activation, likely after its binding to PSMA3 (α7) subunit through its intrinsically disordered region. As a consequence, galectin-3 is unable to induce red blood cells agglutination when preincubated with cc-proteasome. These results highlight potential novel physio- and pathologic functions for the extracellular proteasome.
- Published
- 2022
24. Druggable redox pathways against M. abscessus in cystic fibrosis patient-derived airway organoids
- Author
-
Stephen Adonai Leon-Icaza, Salimata Bagayoko, Romain Vergé, Nino Iakobachvili, Chloé Ferrand, Talip Aydogan, Celia Bernard, Angelique Sanchez Dafun, Marlène Murris-Espin, Julien Mazières, Pierre Jean Bordignon, Serge Mazères, Pascale Bernes-Lasserre, Victoria Ramé, Jean-Michel Lagarde, Julien Marcoux, Marie Pierre Bousquet, Christian Chalut, Christophe Guilhot, Hans Clevers, Peter J. Peters, Virginie Molle, Geanncarlo Lugo-Villarino, Kaymeuang Cam, Laurence Berry, Etienne Meunier, and Céline Cougoule
- Abstract
Mycobacterium abscessus(Mabs) drives life-shortening mortality in cystic fibrosis (CF) patients, primarily because of its resistance to chemotherapeutic agents. To date, our knowledge on the host and bacterial determinants driving Mabs pathology in CF patient lung remains rudimentary. Here, we used human airway organoids (AOs) microinjected with smooth (S) or rough (R-)Mabs to evaluate bacteria fitness, host responses to infection, and new treatment efficacy. We show that S Mabs formed biofilm, R Mabs formed cord serpentines and displayed a higher virulence. While Mabs infection triggers enhanced oxidative stress, pharmacological activation of antioxidant pathways resulted in better control of Mabs growth. Genetic and pharmacological inhibition of the CFTR is associated with better growth and higher virulence of S and R Mabs. Finally, pharmacological activation of antioxidant pathways inhibited Mabs growth and improved efficacy in combination with cefoxitin, a first line antibiotic. In conclusion, we have established AOs as a suitable human system to decipher mechanisms of CF-driven respiratory infection by Mabs and propose antioxidants as a potential host-directed strategy to improve Mabs infection control.
- Published
- 2022
- Full Text
- View/download PDF
25. Proteasome complexes experience profound structural and functional rearrangements throughout mammalian spermatogenesis
- Author
-
Sandrine Lise, Adrien Schahl, Christine Kervarrec, Paula C. A. da Fonseca, Charles Pineau, Matthieu Chavent, Angelique Sanchez Dafun, Marie-Pierre Bousquet, Julien Marcoux, Odile Burlet-Schiltz, Thomas Menneteau, Dušan Živković, Ana Toste Rêgo, Institut de pharmacologie et de biologie structurale (IPBS), Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Centre National de la Recherche Scientifique (CNRS), Proteomics Core Facility (Protim), Université de Rennes (UR)-Plateforme Génomique Santé Biogenouest®, MRC Laboratory of Molecular Biology [Cambridge, UK] (LMB), University of Cambridge [UK] (CAM)-Medical Research Council, Centre National de la Recherche Scientifique (CNRS)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées, Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Plateforme Génomique Santé Biogenouest®, Institut de recherche en santé, environnement et travail (Irset), Université d'Angers (UA)-Université de Rennes (UR)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Laboratory of Molecular Biology [Cambridge], and Medical Research Council
- Subjects
Male ,Proteasome Endopeptidase Complex ,Protein subunit ,[SDV]Life Sciences [q-bio] ,Population ,[SDV.BC.BC]Life Sciences [q-bio]/Cellular Biology/Subcellular Processes [q-bio.SC] ,03 medical and health sciences ,Meiosis ,medicine ,Humans ,HDX-MS ,education ,Spermatogenesis ,Mitosis ,interactomics ,[SDV.BDD.GAM]Life Sciences [q-bio]/Development Biology/Gametogenesis ,030304 developmental biology ,mass spectrometry ,0303 health sciences ,education.field_of_study ,Multidisciplinary ,[SDV.BBM.BS]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Structural Biology [q-bio.BM] ,Chemistry ,030302 biochemistry & molecular biology ,Signal transducing adaptor protein ,Spermatogonia ,Cell biology ,Synaptonemal complex ,medicine.anatomical_structure ,proteasome ,Proteasome ,Proteolysis ,Germ cell - Abstract
During spermatogenesis, spermatogonia undergo a series of mitotic and meiotic divisions on their path to spermatozoa. To achieve this, a succession of complex processes requiring high proteolytic activity are in part orchestrated by the proteasome. The spermatoproteasome (s20S) is a proteasome subtype specific to the developing gametes, in which the gamete-specific α4s subunit replaces the α4 isoform found in the constitutive proteasome (c20S). Although the s20S is conserved across species and was shown to be crucial for germ cell development, its mechanism, function and structure remain incompletely characterized. Here, we used advanced mass spectrometry (MS) methods to map the composition of proteasome complexes and their interactomes throughout spermatogenesis. We observed that the s20S becomes highly activated as germ cells enter meiosis, mainly through a particularly extensive 19S activation and, to a lesser extent, PA200 binding. Additionally, the proteasome population shifts from predominantly c20S (98%) to predominantly s20S (>82-92%) during differentiation, presumably due to the shift from α4 to α4s expression. We demonstrated that s20S, but not c20S, interacts with components of the meiotic synaptonemal complex, where it may localize via association with the PI31 adaptor protein. In vitro, s20S preferentially binds to 19S, and displays higher trypsin- and chymotrypsin-like activities, both with and without PA200 activation. Moreover, using MS methods to monitor protein dynamics, we identified significant differences in domain flexibility between α4 and α4s. We propose that these differences induced by α4s incorporation result in significant changes in the way the s20S interacts with its partners, and dictate its role in germ cell differentiation.
- Published
- 2021
- Full Text
- View/download PDF
26. Mass Spectrometry-based Absolute Quantification of 20S Proteasome Status for Controlled Ex-vivo Expansion of Human Adipose-derived Mesenchymal Stromal/Stem Cells
- Author
-
Luc Garrigues, Florence Roux-Dalvai, Emmanuelle Mouton-Barbosa, Mathilde Beau, Luc Sensebé, Anne Gonzalez-de-Peredo, Dusan Zivkovic, Marie-Pierre Bousquet, Marie-Laure Renoud, Thomas Menneteau, Odile Burlet-Schiltz, Alexandre Stella, Bertrand Fabre, François Amalric, Isabelle Ader, Institut de pharmacologie et de biologie structurale (IPBS), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS), Institut de médecine moléculaire de Rangueil (I2MR), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-IFR150-Institut National de la Santé et de la Recherche Médicale (INSERM), Equipe 1, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM), STROMALab, Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Ecole Nationale Vétérinaire de Toulouse (ENVT), Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Etablissement Français du Sang-Centre National de la Recherche Scientifique (CNRS), Université de Montréal [Montréal], Centre National de la Recherche Scientifique (CNRS)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées, Centre National de la Recherche Scientifique (CNRS)-Ecole Nationale Vétérinaire de Toulouse (ENVT), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Etablissement Français du Sang-Institut National de la Santé et de la Recherche Médicale (INSERM), and Université de Montréal (UdeM)
- Subjects
Proteasome Endopeptidase Complex ,Stromal cell ,[SDV]Life Sciences [q-bio] ,Cell ,Protein degradation ,SILAC ,Biochemistry ,Mass Spectrometry ,Cell Line ,Analytical Chemistry ,Interferon-gamma ,03 medical and health sciences ,Absolute quantification ,[SDV.BBM.GTP]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Genomics [q-bio.GN] ,Stable isotope labeling by amino acids in cell culture ,medicine ,Humans ,Stem cells ,Molecular Biology ,Protein complex analysis ,Cell Proliferation ,030304 developmental biology ,0303 health sciences ,Chemistry ,Research ,Human Adipose-derived Mesenchymal Stromal/Stem Cells ,030302 biochemistry & molecular biology ,Mesenchymal stem cell ,20S Proteasome ,Reproducibility of Results ,Targeted mass spectrometry ,Cell Differentiation ,Mesenchymal Stem Cells ,stoichiometry ,3. Good health ,Cell biology ,Oxygen ,medicine.anatomical_structure ,Proteasome ,Selected reaction monitoring ,Stem cell - Abstract
20S proteasomes are very heterogeneous protein complexes involved in many cellular processes. In the present study, we combined an MRM-based assay with the production and purification of entire SILAC labelled proteasome to monitor absolute quantities of the different 20S proteasome subtypes in various human cells and tissues. This method applied to adipocyte-derived stem cells (ADSCs) amplified under various conditions highlights an increased expression of immunoproteasome when this type of cell is primed with IFNγ or amplified in a 20% O2 environment., Graphical Abstract Highlights Design of an MRM assay to determine the absolute quantity and stoichiometry of ubiquitous and tissue-specific human 20S proteasome subtypes. Use of purified isotopically labelled 20S proteasome as internal standard for accurate quantification. Variation in the expression of immunoproteasome in adipocyte-derived stem cells (ADSCs) grown under different O2 levels might be causal for change in cells differentiation capacity. The status of 20S proteasome during ADSCs expansion might constitute an additional relevant quality control parameter to contribute to predict, among other quality markers, their therapeutic capacity., The proteasome controls a multitude of cellular processes through protein degradation and has been identified as a therapeutic target in oncology. However, our understanding of its function and the development of specific modulators are hampered by the lack of a straightforward method to determine the overall proteasome status in biological samples. Here, we present a method to determine the absolute quantity and stoichiometry of ubiquitous and tissue-specific human 20S proteasome subtypes based on a robust, absolute SILAC-based multiplexed LC-Selected Reaction Monitoring (SRM) quantitative mass spectrometry assay with high precision, accuracy, and sensitivity. The method was initially optimized and validated by comparison with a reference ELISA assay and by analyzing the dynamics of catalytic subunits in HeLa cells following IFNγ-treatment and in range of human tissues. It was then successfully applied to reveal IFNγ- and O2-dependent variations of proteasome status during primary culture of Adipose-derived-mesenchymal Stromal/Stem Cells (ADSCs). The results show the critical importance of controlling the culture conditions during cell expansion for future therapeutic use in humans. We hypothesize that a shift from the standard proteasome to the immunoproteasome could serve as a predictor of immunosuppressive and differentiation capacities of ADSCs and, consequently, that quality control should include proteasomal quantification in addition to examining other essential cell parameters. The method presented also provides a new powerful tool to conduct more individualized protocols in cancer or inflammatory diseases where selective inhibition of the immunoproteasome has been shown to reduce side effects.
- Published
- 2019
- Full Text
- View/download PDF
27. Role of proteasome subtypes in the processing of tumor antigens and the degradation of oxidized proteins
- Author
-
Benoit Van den Eynde, Joanna Abi Habib, Nathalie Vigneron, Etienne De Plaen, Vincent Stroobant, Marie-Pierre Bousquet, and Joris Messens
- Subjects
Immunology ,Molecular Biology - Published
- 2022
- Full Text
- View/download PDF
28. Phosphoproteomics identifies PI3K inhibitor-selective adaptive responses in pancreatic cancer cell therapy and resistance
- Author
-
Fernanda Ramos-Delgado, Thibault Douche, Frédéric Pont, Paola Cappello, Anne Gomez-Brouchet, Julie Guillermet-Guibert, Emmanuelle Mouton-Barbosa, Odile Burlet-Schiltz, Barbara Garmy-Susini, Emilio Hirsch, Coralie Cayron, Célia Cintas, Benoît Thibault, Marie-Pierre Bousquet, Nicole Therville, Maximilian Reichert, Camille Guyon, Zahra Dantes, Centre de Recherches en Cancérologie de Toulouse (CRCT), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), European Project: 675392,H2020,H2020-MSCA-ITN-2015,Phd(2015), and Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)
- Subjects
Gene isoform ,Proteomics ,Cancer Research ,[SDV]Life Sciences [q-bio] ,Cell ,pancreatic cancer ,Biology ,PI3K ,03 medical and health sciences ,chemistry.chemical_compound ,Mice ,0302 clinical medicine ,Pancreatic cancer ,Cell Line, Tumor ,medicine ,Animals ,Humans ,cell signaling ,LY294002 ,Protein kinase B ,PI3K/AKT/mTOR pathway ,030304 developmental biology ,Phosphoinositide-3 Kinase Inhibitors ,0303 health sciences ,drug resistance ,Phosphoproteomics ,Cancer ,phosphoproteomics ,medicine.disease ,targeted therapy ,3. Good health ,Pancreatic Neoplasms ,medicine.anatomical_structure ,Oncology ,chemistry ,Apoptosis ,030220 oncology & carcinogenesis ,Cancer research - Abstract
The PI3K pathway is highly active in human cancers. The four class I isoforms of PI3K are activated by distinct mechanisms leading to a common downstream signaling. Their downstream redundancy is thought to be responsible for treatment failures of PI3K inhibitors. We challenged this concept, by mapping the differential phosphoproteome evolution in response to PI3K inhibitors with different isoform selectivity patterns in pancreatic cancer, a disease currently without effective therapy. In this cancer, the PI3K signal was shown to control cell proliferation. We compared the effects of LY294002 that inhibit with equal potency all class I isoenzymes and downstream mTOR with the action of inhibitors with higher isoform-selectivity towards PI3Kα, PI3Kβ or PI3Kγ (namely A66, TGX-221 and AS-252424). A bioinformatics global pathway analysis of phosphoproteomics data allowed us to identify common and specific signals activated by PI3K inhibitors supported by the biological data. AS-252424 was the most effective treatment and induced apoptotic pathway activation as well as the highest changes in global phosphorylation-regulated cell signal. However, AS-252424 treatment induced re-activation of Akt, therefore decreasing the treatment outcome on cell survival. Reversely, AS-252424 and A66 combination treatment prevented p-Akt reactivation and led to synergistic action in cell lines and patient organoids. The combination of clinically approved α-selective BYL-719 with γ-selective IPI-549 was more efficient than single molecule treatment on xenograft growth. Mapping unique adaptive signaling responses to isoform-selective PI3K inhibition will help to design better combinative treatments that prevent the induction of selective compensatory signals.Graphical abstractSignificanceHalf of all human cancers show increased PI3K activity but the mutational pattern of the PI3K pathway is not sufficient to predict sensitivity to PI3K inhibitors. By identifying for the first time specific signaling induced by PI3K inhibitors with different isoform-selectivity patterns, we provide insight in how to handle heterogeneity of PI3K expression in tumor samples for the choice of available PI3K-targetting drugs. Our work provides a roadmap to target the PI3K pathway, balancing the use of isoform-selective PI3K inhibitors with personalized information extending beyond the specific mutational status.
- Published
- 2021
29. Efficiency of the four proteasome subtypes to degrade ubiquitinated or oxidized proteins
- Author
-
Antonia Busse, Khadija Wahni, Vincent Stroobant, Marie-Pierre Bousquet, Joris Messens, Dusan Zivkovic, Benoît Guillaume, Joanna Abi Habib, Etienne De Plaen, Nathalie Vigneron, Benoît Van den Eynde, Department of Bio-engineering Sciences, Structural Biology Brussels, UCL - SSS/DDUV/GECE - Génétique cellulaire, Institut de pharmacologie et de biologie structurale (IPBS), Centre National de la Recherche Scientifique (CNRS)-Université Toulouse III - Paul Sabatier (UT3), and Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées
- Subjects
Cyclin-Dependent Kinase Inhibitor p21 ,Proteasome Endopeptidase Complex ,Circular dichroism ,Calmodulin ,[SDV]Life Sciences [q-bio] ,Tau protein ,lcsh:Medicine ,medicine.disease_cause ,Article ,Proto-Oncogene Proteins c-myc ,03 medical and health sciences ,Ubiquitylated proteins ,Ubiquitin ,medicine ,Homeostasis ,Humans ,Protein folding ,lcsh:Science ,030304 developmental biology ,0303 health sciences ,Multidisciplinary ,Proteasome ,biology ,Chemistry ,lcsh:R ,030302 biochemistry & molecular biology ,Ubiquitination ,In vitro ,Cell biology ,HEK293 Cells ,Proteolysis ,biology.protein ,lcsh:Q ,Hemoglobin ,Oxidation-Reduction ,Oxidative stress - Abstract
The proteasome is responsible for selective degradation of proteins. It exists in mammalian cells under four main subtypes, which differ by the combination of their catalytic subunits: the standard proteasome (β1–β2–β5), the immunoproteasome (β1i–β2i–β5i) and the two intermediate proteasomes (β1–β2–β5i and β1i–β2–β5i). The efficiency of the four proteasome subtypes to degrade ubiquitinated or oxidized proteins remains unclear. Using cells expressing exclusively one proteasome subtype, we observed that ubiquitinated p21 and c-myc were degraded at similar rates, indicating that the four 26S proteasomes degrade ubiquitinated proteins equally well. Under oxidative stress, we observed a partial dissociation of 26S into 20S proteasomes, which can degrade non-ubiquitinated oxidized proteins. Oxidized calmodulin and hemoglobin were best degraded in vitro by the three β5i-containing 20S proteasomes, while their native forms were not degraded. Circular dichroism analyses indicated that ubiquitin-independent recognition of oxidized proteins by 20S proteasomes was triggered by the disruption of their structure. Accordingly, β5i-containing 20S proteasomes degraded unoxidized naturally disordered protein tau, while 26S proteasomes did not. Our results suggest that the three β5i-containing 20S proteasomes, namely the immunoproteasome and the two intermediate proteasomes, might help cells to eliminate proteins containing disordered domains, including those induced by oxidative stress.
- Published
- 2020
- Full Text
- View/download PDF
30. Pharmacologic Normalization of Pancreatic Cancer-Associated Fibroblast Secretome Impairs Prometastatic Cross-Talk With Macrophages
- Author
-
Ilaria Cascone, Marjorie Fanjul, Véronique Gigoux, Marie Pierre Bousquet, Christine Jean, Jerome Raffenne, Stéphane Pyronnet, Julia Rochotte, Rémy Nicolle, Matteo Ponzo, Herbert A. Schmid, Cindy Neuzillet, Yvan Martineau, Richard Tomasini, Thibault Douché, Stéphanie Cassant-Sourdy, Jérôme Cros, Jérémy Nigri, Camille Duluc, Alexia Brunel, Corinne Bousquet, Aurélie Perraud, Ivan Bièche, Muriel Mathonnet, Gilles Carpentier, Rémi Samain, Centre de Recherches en Cancérologie de Toulouse (CRCT), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Hôpital Beaujon, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7)-Hôpital Beaujon [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Département d'Oncologie Médicale [Institut Curie, Paris], Institut Curie [Paris], Université de Versailles Saint-Quentin-en-Yvelines - UFR Sciences de la santé Simone Veil (UVSQ Santé), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Université de Limoges (UNILIM), Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Laboratoire de recherche sur la croissance cellulaire, la réparation et la régénération tissulaires (LRCCRRT), Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-Centre National de la Recherche Scientifique (CNRS), Novartis Pharmaceutical Corporation, Ligue Nationale Contre le Cancer - Paris, Ligue Nationale Contre le Cancer (LNCC), Institut de pharmacologie et de biologie structurale (IPBS), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS), This work was supported by the Ligue Nationale Contre le Cancer, the Labex Toucan, the French Institut National du Cancer INCa (PLBIO15-115, PAIR18-080, PAIR18-082), Association pour la Recherche sur le Cancer ARC (20191209786), and the Plan Cancer 3R. Also supported by a fellowship from the Fondation pour la Recherche Médicale (FRM40493) (R.S. and T.D.), and a fellowship from the Ligue Nationale Contrele Cancer (C.J. and A.B.)., ANR-11-LABX-0068,TOUCAN,Analyse intégrée de la résistance dans les cancers hématologiques(2011), Ligue Nationnale Contre le Cancer, Centre National de la Recherche Scientifique (CNRS)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées, Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Université de Toulouse (UT)-Université de Toulouse (UT)-Centre National de la Recherche Scientifique (CNRS), Douché, Thibaut, and Analyse intégrée de la résistance dans les cancers hématologiques - - TOUCAN2011 - ANR-11-LABX-0068 - LABX - VALID
- Subjects
0301 basic medicine ,Male ,WT, wild type ,Myeloid ,medicine.medical_treatment ,RC799-869 ,Metastasis ,Mice ,0302 clinical medicine ,PCR, polymerase chain reaction ,Cancer-Associated Fibroblasts ,GSEA, gene set enrichment analysis ,Pancreatic Adenocarcinoma ,GBSS, Grey’s balanced salt solution ,Secretome ,Original Research ,Aged, 80 and over ,sst1, somatostatin receptor subtype 1 ,mTOR, mechanistic target of rapamycin ,PSC, pancreatic stellate cell ,Gastroenterology ,Stromal Cell Cross-Talk ,KOsst1, Knock-out ,LNR, lymph node ratio ,ELISA, enzyme-linked immunosorbent assay ,PDA, pancreatic ductal adenocarcinoma ,Diseases of the digestive system. Gastroenterology ,Middle Aged ,LAR, long-acting release ,mRNA, messenger RNA ,3. Good health ,ECM, extracellular matrix ,MS, mass-spectrometry ,FFPE, formalin-fixed paraffin-embedded ,medicine.anatomical_structure ,Adenocarcinoma ,030211 gastroenterology & hepatology ,Female ,RNAseq, RNA sequencing ,TAM, tumor-associated macrophage ,αSMA, α smooth muscle actin ,Somatostatin ,Stroma Normalization ,Carcinoma, Pancreatic Ductal ,Stromal cell ,education ,KPC, Pdx-1-Cre ,PBS, phosphate-buffered saline ,[SDV.CAN]Life Sciences [q-bio]/Cancer ,Mice, Transgenic ,CSF-1-R, colony stimulating factor 1 receptor ,03 medical and health sciences ,[SDV.CAN] Life Sciences [q-bio]/Cancer ,Stroma ,Pancreatic cancer ,medicine ,Animals ,Humans ,PDX, patient-derived xenograft ,Aged ,CAF, cancer-associated fibroblast ,Hepatology ,CSF-1, colony stimulating factor 1 ,business.industry ,Growth factor ,Macrophages ,LSL-KrasG12D/+, LSL-Trp53R172H/+ ,Antimetastatic Therapy ,medicine.disease ,Hormones ,Mice, Inbred C57BL ,Pancreatic Neoplasms ,CAFhTERT, human Telomerase reverse transcriptase ,030104 developmental biology ,Somatostatin Receptor ,Cancer research ,BSA, bovine serum albumin ,GPCR, G-protein–coupled receptor subtype ,business - Abstract
Background & Aims Cancer-associated fibroblasts (CAFs) from pancreatic adenocarcinoma (PDA) present high protein synthesis rates. CAFs express the G-protein–coupled somatostatin receptor sst1. The sst1 agonist SOM230 blocks CAF protumoral features in vitro and in immunocompromised mice. We have explored here the therapeutic potential of SOM230, and underlying mechanisms, in immunocompetent models of murine PDA mimicking the heavy fibrotic and immunosuppressive stroma observed in patient tumors. Methods Large-scale mass spectrometry analyses were performed on media conditioned from 9 patient PDA-derived CAF primary cultures. Spontaneous transgenic and experimental (orthotopic co-graft of tumor cells plus CAFs) PDA-bearing mice were longitudinally ultrasound-monitored for tumor and metastatic progression. Histopathology and flow cytometry analyses were performed on primary tumors and metastases. Stromal signatures were functionally validated through bioinformatics using several published, and 1 original, PDA database. Results Proteomics on the CAF secretome showed that SOM230 controls stromal activities including inflammatory responses. Among the identified secreted proteins, we validated that colony-stimulating factor 1 (CSF-1) (a macrophage growth factor) was reduced by SOM230 in the tumor and plasma of PDA-harboring mice, alongside intratumor stromal normalization (reduced CAF and macrophage activities), and dramatic metastasis reduction. In transgenic mice, these SOM230 benefits alleviate the chemotherapy-induced (gemcitabine) immunosuppressive stroma reshaping. Mechanistically, SOM230 acts in vivo on CAFs through sst1 to disrupt prometastatic CAF production of CSF-1 and cross-talk with macrophages. We found that in patients, stromal CSF-1 was associated with aggressive PDA forms. Conclusions We propose SOM230 as an antimetastatic therapy in PDA for its capacity to remodel the fibrotic and immunosuppressive myeloid stroma. This pharmacotherapy should benefit PDA patients treated with chemotherapies., Graphical abstract
- Published
- 2020
- Full Text
- View/download PDF
31. The inducible β5i proteasome subunit contributes to proinsulin degradation in GRP94-deficient β-cells and is overexpressed in type 2 diabetes pancreatic islets
- Author
-
Michal Marzec, Sarah J. Richardson, Kristian Klindt, Anna Walentinsson, Marie-Pierre Bousquet, Jette Bach Agergaard, Thomas Mandrup-Poulsen, Noel G. Morgan, Phillip Alexander Keller Andersen, Tenna Holgersen Bryde, Christian Kronborg Nielsen, Tina Dahlby, Dusan Zivkovic, Muhammad Saad Khilji, Celina Pihl, Björn Tyrberg, Sophie Emilie Bresson, Danielle Verstappen, Institut de pharmacologie et de biologie structurale (IPBS), Centre National de la Recherche Scientifique (CNRS)-Université Toulouse III - Paul Sabatier (UT3), and Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées
- Subjects
0301 basic medicine ,medicine.medical_specialty ,endocrine system ,Proteasome Endopeptidase Complex ,Protein Folding ,Physiology ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,Protein subunit ,[SDV]Life Sciences [q-bio] ,GRP94 ,Protein degradation ,proinsulin degradation ,restoration of proinsulin ,03 medical and health sciences ,Gene Knockout Techniques ,Islets of Langerhans ,0302 clinical medicine ,Physiology (medical) ,Internal medicine ,Insulin-Secreting Cells ,Insulin Secretion ,medicine ,Animals ,Humans ,Proinsulin ,Membrane Glycoproteins ,biology ,Chemistry ,Pancreatic islets ,Insulin ,Endoplasmic reticulum ,Endoplasmic Reticulum-Associated Degradation ,Middle Aged ,β5i ,Endoplasmic Reticulum Stress ,Cell biology ,Rats ,030104 developmental biology ,Endocrinology ,medicine.anatomical_structure ,proteasome ,Proteasome ,Diabetes Mellitus, Type 2 ,030220 oncology & carcinogenesis ,Chaperone (protein) ,biology.protein ,Female - Abstract
Proinsulin is a misfolding-prone protein, and its efficient breakdown is critical when β-cells are confronted with high-insulin biosynthetic demands, to prevent endoplasmic reticulum stress, a key trigger of secretory dysfunction and, if uncompensated, apoptosis. Proinsulin degradation is thought to be performed by the constitutively expressed standard proteasome, while the roles of other proteasomes are unknown. We recently demonstrated that deficiency of the proinsulin chaperone glucose-regulated protein 94 (GRP94) causes impaired proinsulin handling and defective insulin secretion associated with a compensated endoplasmic reticulum stress response. Taking advantage of this model of restricted folding capacity, we investigated the role of different proteasomes in proinsulin degradation, reasoning that insulin secretory dynamics require an inducible protein degradation system. We show that the expression of only one enzymatically active proteasome subunit, namely, the inducible β5i-subunit, was increased in GRP94 CRISPR/Cas9 knockout (KO) cells. Additionally, the level of β5i-containing intermediate proteasomes was significantly increased in these cells, as was β5i-related chymotrypsin-like activity. Moreover, proinsulin levels were restored in GRP94 KO upon β5i small interfering RNA-mediated knockdown. Finally, the fraction of β-cells expressing the β5i-subunit is increased in human islets from type 2 diabetes patients. We conclude that β5i is an inducible proteasome subunit dedicated to the degradation of mishandled proinsulin.
- Published
- 2020
- Full Text
- View/download PDF
32. The insulin-degrading enzyme is an allosteric modulator of the 20S proteasome and a potential competitor of the 19S
- Author
-
Danilo Milardi, Efthymia Ioanna Koufogeorgou, Grazia R. Tundo, Diego Sbardella, Julien Marcoux, Giuseppe Grasso, Paola Cozza, Stefano Marini, Anna Maria Santoro, Chiara Ciaccio, Marie Pierre Bousquet-Dubouch, Andrea Coletta, Massimo Coletta, Institut de pharmacologie et de biologie structurale (IPBS), Centre National de la Recherche Scientifique (CNRS)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées, Laboratoire de Génie Protéique et Cellulaire (LGPC), Université de La Rochelle (ULR), Department of Experimental Medicine and Biochemical Sciences, and Università degli Studi di Roma Tor Vergata [Roma]
- Subjects
0301 basic medicine ,Mutant ,Open-close 20S equilibrium ,Insulysin ,0302 clinical medicine ,Tandem Mass Spectrometry ,Yeasts ,Insulin-degrading enzyme ,IDE-20S molecular docking ,Chromatography, High Pressure Liquid ,ComputingMilieux_MISCELLANEOUS ,chemistry.chemical_classification ,Chromatography ,Tumor ,[SDV.BBM.BS]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Structural Biology [q-bio.BM] ,Molecular Docking Simulation ,Native Polyacrylamide Gel Electrophoresis ,IDE-20S proteasome interaction ,Allosteric Regulation ,Cell Line, Tumor ,HEK293 Cells ,Humans ,Kinetics ,Proteasome Endopeptidase Complex ,Protein Binding ,Protein Structure, Quaternary ,Protein Structure, Tertiary ,Biochemistry ,High Pressure Liquid ,Molecular Medicine ,Protein Structure ,Allosteric modulator ,Protein subunit ,Allosteric regulation ,Insulin-degrading enzyme, IDE-20S proteasome interaction, IDE-20S molecular docking, Open-close 20S equilibrium ,Cell Line ,Quaternary ,03 medical and health sciences ,Cellular and Molecular Neuroscience ,Settore BIO/10 ,Molecular Biology ,Pharmacology ,Cell Biology ,030104 developmental biology ,Enzyme ,chemistry ,Proteasome ,Docking (molecular) ,Tertiary ,030217 neurology & neurosurgery - Abstract
The interaction of insulin-degrading enzyme (IDE) with the main intracellular proteasome assemblies (i.e, 30S, 26S and 20S) was analyzed by enzymatic activity, mass spectrometry and native gel electrophoresis. IDE was mainly detected in association with assemblies with at least one free 20S end and biochemical investigations suggest that IDE competes with the 19S in vitro. IDE directly binds the 20S and affects its proteolytic activities in a bimodal fashion, very similar in human and yeast 20S, inhibiting at (IDE) 30 nM and activating at (IDE) 30 nM. Only an activating effect is observed in a yeast mutant locked in the "open" conformation (i.e., the alpha-3 Delta N 20S), envisaging a possible role of IDE as modulator of the 20S "open"-"closed" allosteric equilibrium. Protein-protein docking in silico proposes that the interaction between IDE and the 20S could involve the C-term helix of the 20S alpha-3 subunit which regulates the gate opening of the 20S.
- Published
- 2018
- Full Text
- View/download PDF
33. Anthropological perspectives on Miyupimaatisiiun and the integration of oral health in primary care in the Cree communities of Northern Quebec
- Author
-
Shrivastava, Richa, primary, Campeau, Roxane, additional, Couturier, Yves, additional, Torrie, Jill, additional, Girard, Felix, additional, Marie-Pierre, Bousquet, additional, and Emami, Elham, additional
- Published
- 2020
- Full Text
- View/download PDF
34. Probing Protein Interaction Networks by Combining MS-Based Proteomics and Structural Data Integration
- Author
-
Emmanuelle Mouton-Barbosa, Guillaume Postic, Victor Reys, Gilles Labesse, Raphael Guerois, Yves Vandenbrouck, Pierre Tufféry, Sarah Cianférani, Jessica Andreani, Julien Marcoux, Marie-Pierre Bousquet, Odile Burlet-Schiltz, Unité de Biologie Fonctionnelle et Adaptative (BFA (UMR_8251 / U1133)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Institut de pharmacologie et de biologie structurale (IPBS), Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Centre National de la Recherche Scientifique (CNRS), Centre de Biochimie Structurale [Montpellier] (CBS), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Institut de Biologie Intégrative de la Cellule (I2BC), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS), Laboratoire de Biologie à Grande Échelle (BGE - UMR S1038), Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut de Recherche Interdisciplinaire de Grenoble (IRIG), Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Grenoble Alpes (UGA), Laboratoire de Spectrométrie de Masse BioOrganique [Strasbourg] (LSMBO), Département Sciences Analytiques et Interactions Ioniques et Biomoléculaires (DSA-IPHC), Institut Pluridisciplinaire Hubert Curien (IPHC), Université de Strasbourg (UNISTRA)-Université de Haute-Alsace (UHA) Mulhouse - Colmar (Université de Haute-Alsace (UHA))-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Centre National de la Recherche Scientifique (CNRS)-Université de Strasbourg (UNISTRA)-Université de Haute-Alsace (UHA) Mulhouse - Colmar (Université de Haute-Alsace (UHA))-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Centre National de la Recherche Scientifique (CNRS)-Institut Pluridisciplinaire Hubert Curien (IPHC), Université de Strasbourg (UNISTRA)-Université de Haute-Alsace (UHA) Mulhouse - Colmar (Université de Haute-Alsace (UHA))-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Centre National de la Recherche Scientifique (CNRS)-Université de Strasbourg (UNISTRA)-Université de Haute-Alsace (UHA) Mulhouse - Colmar (Université de Haute-Alsace (UHA))-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Centre National de la Recherche Scientifique (CNRS), Assemblage moléculaire et intégrité du génome (AMIG), Département Biochimie, Biophysique et Biologie Structurale (B3S), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS)-Institut de Biologie Intégrative de la Cellule (I2BC), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Paris (UP), Centre National de la Recherche Scientifique (CNRS)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées, Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Université de Strasbourg (UNISTRA)-Centre National de la Recherche Scientifique (CNRS)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Université de Strasbourg (UNISTRA)-Centre National de la Recherche Scientifique (CNRS), and Centre National de la Recherche Scientifique (CNRS)
- Subjects
0301 basic medicine ,Multiprotein complex ,Computer science ,computational proteomics ,[SDV]Life Sciences [q-bio] ,Computational biology ,computer.software_genre ,Proteomics ,Biochemistry ,03 medical and health sciences ,Structural bioinformatics ,proteomics ,Protein Interaction Mapping ,Added value ,Short linear motif ,[SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology ,Protein Interaction Maps ,protein interaction networks ,Databases, Protein ,ComputingMilieux_MISCELLANEOUS ,mass spectrometry ,protein complexes ,030102 biochemistry & molecular biology ,Computational Biology ,Proteins ,General Chemistry ,computer.file_format ,structural bioinformatics ,Protein Data Bank ,short linear motifs ,[SDV.BBM.BS]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Biomolecules [q-bio.BM] ,030104 developmental biology ,ComputingMethodologies_PATTERNRECOGNITION ,remote homology ,DECIPHER ,computer ,Data integration - Abstract
International audience; Protein-protein interactions play a major role in the molecular machinery of life, and various techniques such as AP-MS are dedicated to their identification. However, those techniques return lists of proteins devoid of organizational structure, not detailing which proteins interact with which others. Proposing a hierarchical view of the interactions between the members of the flat list becomes highly tedious for large data sets when done by hand. To help hierarchize this data, we introduce a new bioinformatics protocol that integrates information of the multimeric protein 3D structures available in the Protein Data Bank using remote homology detection, as well as information related to Short Linear Motifs and interaction data from the BioGRID. We illustrate on two unrelated use-cases of different complexity how our approach can be useful to decipher the network of interactions hidden in the list of input proteins, and how it provides added value compared to state-of-the-art resources such as Interactome3D or STRING. Particularly, we show the added value of using homology detection to distinguish between orthologs and paralogs, and to distinguish between core obligate and more facultative interactions. We also demonstrate the potential of considering interactions occurring through Short Linear Motifs.
- Published
- 2020
- Full Text
- View/download PDF
35. The intermediate proteasome is constitutively expressed in pancreatic beta cells and upregulated by stimulatory, low concentrations of interleukin 1 β
- Author
-
Sophie Emilie Bresson, Kristian Klindt, Thomas Mandrup-Poulsen, Phillip Alexander Keller Andersen, Marie-Pierre Bousquet-Dubouch, Celina Pihl, Tenna Holgersen Bryde, Tina Dahlby, Dusan Zivkovic, Muhammad Saad Khilji, Michala Prause, Michal Marzec, Danielle Verstappen, Björn Tyrberg, Institut de pharmacologie et de biologie structurale (IPBS), Centre National de la Recherche Scientifique (CNRS)-Université Toulouse III - Paul Sabatier (UT3), and Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées
- Subjects
0301 basic medicine ,Physiology ,Molecular biology ,[SDV]Life Sciences [q-bio] ,Interleukin-1beta ,Pathology and Laboratory Medicine ,Jurkat cells ,Biochemistry ,Autoantigens ,Epitope ,Major Histocompatibility Complex ,Jurkat Cells ,Mice ,0302 clinical medicine ,Sequencing techniques ,Endocrinology ,Animal Cells ,Immune Physiology ,Insulin-Secreting Cells ,Medicine and Health Sciences ,Insulin ,RNA-Seq ,Immune Response ,Proinsulin ,Innate Immune System ,Multidisciplinary ,biology ,Chemistry ,RNA sequencing ,Cell biology ,Up-Regulation ,Cytokines ,Medicine ,Cellular Types ,Research Article ,Proteasome Endopeptidase Complex ,Endocrine Disorders ,Protein subunit ,Immune Cells ,Science ,Immunology ,Primary Cell Culture ,Major histocompatibility complex ,03 medical and health sciences ,Signs and Symptoms ,Diagnostic Medicine ,MHC class I ,Diabetes Mellitus ,Animals ,Humans ,Inflammation ,Diabetic Endocrinology ,Histocompatibility Antigens Class I ,Biology and Life Sciences ,Proteins ,Protein Complexes ,Proteasomes ,Cell Biology ,Molecular Development ,Hormones ,Research and analysis methods ,030104 developmental biology ,Molecular biology techniques ,Diabetes Mellitus, Type 1 ,Proteasome ,Cell culture ,Immune System ,Metabolic Disorders ,Proteolysis ,biology.protein ,Clinical Immunology ,Clinical Medicine ,030217 neurology & neurosurgery ,Developmental Biology - Abstract
International audience; A central and still open question regarding the pathogenesis of autoimmune diseases, such as type 1 diabetes, concerns the processes that underlie the generation of MHC-presented autoantigenic epitopes that become targets of autoimmune attack. Proteasomal degradation is a key step in processing of proteins for MHC class I presentation. Different types of proteasomes can be expressed in cells dictating the repertoire of peptides presented by the MHC class I complex. Of particular interest for type 1 diabetes is the proteasomal configuration of pancreatic β cells, as this might facilitate autoantigen presentation by β cells and thereby their T-cell mediated destruction. Here we investigated whether so-called inducible subunits of the proteasome are constitutively expressed in β cells, regulated by inflammatory signals and participate in the formation of active intermediate or immuno-proteasomes. We show that inducible proteasomal subunits are constitutively expressed in human and rodent islets and an insulin-secreting cell-line. Moreover, the β5i subunit is incorporated into active intermediate proteasomes that are bound to 19S or 11S regulatory particles. Finally, inducible subunit expression along with increase in total proteasome activities are further upregulated by low concentrations of IL-1β stimulating proinsulin biosynthesis. These findings suggest that the β cell proteasomal repertoire is more diverse than assumed previously and may be highly responsive to a local inflammatory islet environment.
- Published
- 2020
- Full Text
- View/download PDF
36. Conformational maps of human 20S proteasomes reveal PA28-and immuno-dependent inter-ring crosstalks
- Author
-
Julien Marcoux, Thomas Menneteau, Jean Lesne, Odile Burlet-Schiltz, Julien Parra, Marie-Pierre Bousquet, Dusan Zivkovic, Marie Locard-Paulet, Institut de pharmacologie et de biologie structurale (IPBS), Centre National de la Recherche Scientifique (CNRS)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées, Centre de Biochimie Structurale [Montpellier] (CBS), Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM), Novo Nordisk Foundation Center for Protein Research (CPR), Faculty of Health and Medical Sciences, University of Copenhagen = Københavns Universitet (KU)-University of Copenhagen = Københavns Universitet (KU), Marcoux, Julien, Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), and University of Copenhagen = Københavns Universitet (UCPH)-University of Copenhagen = Københavns Universitet (UCPH)
- Subjects
0301 basic medicine ,Proteasome Endopeptidase Complex ,[CHIM.ANAL] Chemical Sciences/Analytical chemistry ,[SDV.BBM.BS] Life Sciences [q-bio]/Biochemistry, Molecular Biology/Structural Biology [q-bio.BM] ,Science ,Allosteric regulation ,CORE PARTICLE ,INHIBITION ,Muscle Proteins ,General Physics and Astronomy ,Plasma protein binding ,Autoantigens ,Article ,Supramolecular assembly ,General Biochemistry, Genetics and Molecular Biology ,03 medical and health sciences ,0302 clinical medicine ,Allosteric Regulation ,[CHIM.ANAL]Chemical Sciences/Analytical chemistry ,Humans ,Statistical analysis ,YEAST ,Multidisciplinary ,Proteasome ,Mass spectrometry ,[SDV.BBM.BS]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Structural Biology [q-bio.BM] ,Chemistry ,Activator (genetics) ,19S ,26S PROTEASOME ,General Chemistry ,DEGRADATION ,Solvent accessibility ,3. Good health ,030104 developmental biology ,Structural biology ,RESOLUTION ,ACTIVATOR PA28 ,IMMUNOPROTEASOME ,Biophysics ,PROTEOMICS ,030217 neurology & neurosurgery ,Protein Binding - Abstract
Hydrogen-Deuterium eXchange coupled to Mass Spectrometry (HDX-MS) is now common practice in structural biology. However, it is most of the time applied to rather small oligomeric complexes. Here, we report on the use of HDX-MS to investigate conformational differences between the human standard 20S (std20S) and immuno 20S (i20s) proteasomes alone or in complex with PA28αβ or PA28γ activators. Their solvent accessibility is analyzed through a dedicated bioinformatic pipeline including stringent statistical analysis and 3D visualization. These data confirm the existence of allosteric differences between the std20S and i20S at the surface of the α-ring triggered from inside the catalytic β-ring. Additionally, binding of the PA28 regulators to the 20S proteasomes modify solvent accessibility due to conformational changes of the β-rings. This work is not only a proof-of-concept that HDX-MS can be used to get structural insights on large multi-protein complexes in solution, it also demonstrates that the binding of the std20S or i20S subtype to any of its PA28 activator triggers allosteric changes that are specific to this 20S/PA28 pair., Immune cells express immunoproteasomes (i20S), which bind to specialized regulators, contain different catalytic subunits and generate immunogenic peptides. HDX-MS—based assessment of the differences between the conformational dynamics of standard and i20s reveals specific, allosteric changes in i20S and upon regulator binding.
- Published
- 2020
- Full Text
- View/download PDF
37. The intermediate proteasome is constitutively expressed in pancreatic beta cells and upregulated by stimulatory, non-toxic concentrations of interleukin 1 β
- Author
-
Danielle Verstappen, Dusan Zivkovic, Muhammad Saad Khilji, Celina Pihl, Michala Prause, Kristian Klindt, Thomas Mandrup-Poulsen, Sophie Emilie Bresson, Tina Dahlby, Marie-Pierre Bousquet-Dubouch, Michal Marzec, Björn Tyrberg, Nils Billestrup, and Tenna Holgersen Bryde
- Subjects
biology ,Chemistry ,Protein subunit ,Cell ,Epitope ,Cell biology ,medicine.anatomical_structure ,Proteasome ,Downregulation and upregulation ,MHC class I ,biology.protein ,medicine ,Beta (finance) ,Proinsulin - Abstract
A central and still open question regarding the pathogenesis of autoimmune diseases, such as type 1 diabetes, concerns the processes that underlie the generation of MHC-presented autoantigenic epitopes that become targets of autoimmune attack. Proteasomal degradation is a key step in processing of proteins for MHC class I presentation. Different types of proteasomes can be expressed in cells dictating the repertoire of peptides presented by the MHC class I complex. Of particular interest for type 1 diabetes is the proteasomal configuration of pancreatic β cells, as this might facilitate autoantigen presentation by β cells and thereby their T-cell mediated destruction. Here we investigated whether so-called inducible subunits of the proteasome are constitutively expressed in β cells, regulated by inflammatory signals and participate in the formation of active intermediate or immuno-proteasomes.We show that inducible proteasomal subunits are constitutively expressed in human and rodent islets and an insulin-secreting cell-line. Moreover, the β5i subunit is incorporated into active intermediate proteasomes that are bound to 19S or 11S regulatory particles. Finally, inducible subunit expression along with increase in total proteasome activities are further upregulated by non-toxic concentrations of IL-1β stimulating proinsulin biosynthesis. These findings suggest that the β cell proteasomal repertoire is more diverse than assumed previously and may be highly responsive to a local inflammatory islet environment.
- Published
- 2019
- Full Text
- View/download PDF
38. Les Autochtones et le développement à travers le monde
- Author
-
Marie-Pierre Bousquet and Laurence Hamel-Charest
- Published
- 2019
- Full Text
- View/download PDF
39. La blessure qui dormait à poings fermés : l'héritage des pensionnats autochtones au Québec
- Author
-
Marie-Pierre Bousquet, Karl Hele, Marie-Pierre Bousquet, and Karl Hele
- Subjects
- Indigenous peoples--Education--Canada, Indigenous peoples--Canada, Indigenous peoples--Education, Indigenous peoples--Canada--Government relations, Off-reservation boarding schools--Canada, Indigenous peoples--Canada--Social conditions
- Abstract
Au Canada, entre les années 1880 et 1990, plus de 150 000 enfants ont été élèves dans des écoles résidentielles désignées par le gouvernement fédéral comme pensionnats autochtones. Au Québec, on estime que cela a concerné environ 13 000 enfants. Ce livre est consacré à l'expérience particulière du Québec, à ces 13 000 enfants, aux pensionnats qu'ils ont fréquentés, aux adultes qu'ils sont devenus, aux différents acteurs qui ont participé à leur scolarisation et à l'héritage que cette période leur laisse, et nous laisse. Ce livre n'a pas vocation de dénoncer, mais de participer au vaste projet national, lancé par la Commission de vérité et réconciliation, de faire connaître l'histoire et les séquelles des pensionnats. Il veut inciter à la réflexion à partir de travaux de recherche et ouvrir des champs d'investigation pour améliorer les connaissances, afin que la blessure se referme, dans un futur de relations saines avec les peuples autochtones.
- Published
- 2019
40. Top-Down and Intact Protein Mass Spectrometry Data Visualization for Proteoform Analysis Using VisioProt-MS
- Author
-
Julien Marcoux, Jean Lesne, Marie-Pierre Bousquet, Marie Locard-Paulet, Institut de pharmacologie et de biologie structurale (IPBS), Centre National de la Recherche Scientifique (CNRS)-Université Toulouse III - Paul Sabatier (UT3), and Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées
- Subjects
Proteomics ,Mass spectrometry ,Tandem mass spectrometry ,Map visualization ,01 natural sciences ,Biochemistry ,03 medical and health sciences ,Data visualization ,Liquid chromatography–mass spectrometry ,[CHIM.ANAL]Chemical Sciences/Analytical chemistry ,intact protein MS ,Molecular Biology ,lcsh:QH301-705.5 ,030304 developmental biology ,0303 health sciences ,Chromatography ,Molecular mass ,Elution ,Chemistry ,business.industry ,Applied Mathematics ,010401 analytical chemistry ,Intact protein ,Proteins ,0104 chemical sciences ,Computer Science Applications ,LC-MS ,Computational Mathematics ,proteasome ,lcsh:Biology (General) ,top-down ,Commentary ,[INFO.INFO-BI]Computer Science [cs]/Bioinformatics [q-bio.QM] ,business ,Software ,Chromatography, Liquid - Abstract
International audience; The rise of intact protein analysis by mass spectrometry (MS) was accompanied by an increasing need for flexible tools allowing data visualization and analysis. These include inspection of the deconvoluted molecular weights of the proteoforms eluted alongside liquid chromatography (LC) through their representation in three-dimensional (3D) liquid chromatography coupled to mass spectrometry (LC-MS) maps (plots of deconvoluted molecular weights, retention times, and intensity of the MS signal). With this aim, we developed a free and open-source web application named VisioProt-MS (https://masstools.ipbs.fr/mstools/visioprot-ms/). VisioProt-MS is highly compatible with many algorithms and software developed by the community to integrate and deconvolute top-down and intact protein MS data. Its dynamic and userfriendly features greatly facilitate analysis through several graphical representations dedicated to MS and tandem mass spectrometry (MS/MS) analysis of proteoforms in complex samples. Here, we will illustrate the importance of LC-MS map visualization to optimize top-down acquisition/ search parameters and analyze intact protein MS data. We will go through the main features of VisioProt-MS using the human proteasomal 20S core particle as a user-case.
- Published
- 2019
- Full Text
- View/download PDF
41. PIP30/FAM192A is a novel regulator of the nuclear proteasome activator PA28γ
- Author
-
Didier Fesquet, Prisca Boisguerin, Philippe Fort, Corinne Henriquet, Francisca Mechali, Catherine Bonne-Andrea, Véronique Baldin, Séverine Boulon, Thomas Menneteau, Martine Pugnière, Manuelle Ducoux-Petit, Beata Jonik-Nowak, Bertrand Fabre, Olivier Coux, Angus I. Lamond, Odile Burlet-Schiltz, Sylvain de Rossi, Marie-Pierre Bousquet, Centre de recherche en Biologie cellulaire de Montpellier (CRBM), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Institut de pharmacologie et de biologie structurale (IPBS), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS), BioCampus (BCM), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), University of Dundee, Philippe, Fort, Centre de recherche en Biologie Cellulaire (CRBM), Université Montpellier 1 (UM1)-Université Montpellier 2 - Sciences et Techniques (UM2)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Centre National de la Recherche Scientifique (CNRS)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées, BioCampus Montpellier (BCM), and Université Montpellier 1 (UM1)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)
- Subjects
PA28γ ,Proteasome Endopeptidase Complex ,FAM192A ,Regulator ,[SDV.CAN]Life Sciences [q-bio]/Cancer ,[SDV.BC.BC]Life Sciences [q-bio]/Cellular Biology/Subcellular Processes [q-bio.SC] ,[SDV.BID.SPT]Life Sciences [q-bio]/Biodiversity/Systematics, Phylogenetics and taxonomy ,[SDV.BBM.BM] Life Sciences [q-bio]/Biochemistry, Molecular Biology/Molecular biology ,Autoantigens ,03 medical and health sciences ,Protein Domains ,[SDV.CAN] Life Sciences [q-bio]/Cancer ,Cellular stress response ,[SDV.BID.SPT] Life Sciences [q-bio]/Biodiversity/Systematics, Phylogenetics and taxonomy ,[SDV.BC.BC] Life Sciences [q-bio]/Cellular Biology/Subcellular Processes [q-bio.SC] ,Humans ,nuclear proteolysis ,030304 developmental biology ,Cell Nucleus ,0303 health sciences ,Activator (genetics) ,Chemistry ,030302 biochemistry & molecular biology ,Nuclear Proteins ,Proteins ,[SDV.BDD.EO] Life Sciences [q-bio]/Development Biology/Embryology and Organogenesis ,Cajal bodies ,[SDV.BBM.BM]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Molecular biology ,Cell Biology ,Biological Sciences ,Cell biology ,proteasome ,[SDV.BDD.EO]Life Sciences [q-bio]/Development Biology/Embryology and Organogenesis ,PNAS Plus ,Cajal body ,Proteasome ,Phosphorylation ,Coilin ,Casein kinase 2 ,HeLa Cells ,Protein Binding - Abstract
Significance The 20S proteasome is a key actor of the control of protein levels and integrity in cells. To perform its multiple functions, it works with a series of regulators, among which is a nuclear complex called PA28γ. In particular, PA28γ participates in the regulation of cell proliferation and nuclear dynamics. We describe here the characterization of a protein, PIP30/FAM192A, which binds tightly to PA28γ and favors its interaction with the 20S proteasome while inhibiting its association with coilin, a central component of nuclear Cajal bodies. Thus, PIP30/FAM192A critically controls the interactome and, consequently, the functions of PA28γ, and appears to be a previously unidentified player in the fine regulation of intracellular proteostasis in the cell nucleus., PA28γ is a nuclear activator of the 20S proteasome involved in the regulation of several essential cellular processes, such as cell proliferation, apoptosis, nuclear dynamics, and cellular stress response. Unlike the 19S regulator of the proteasome, which specifically recognizes ubiquitylated proteins, PA28γ promotes the degradation of several substrates by the proteasome in an ATP- and ubiquitin-independent manner. However, its exact mechanisms of action are unclear and likely involve additional partners that remain to be identified. Here we report the identification of a cofactor of PA28γ, PIP30/FAM192A. PIP30 binds directly and specifically via its C-terminal end and in an interaction stabilized by casein kinase 2 phosphorylation to both free and 20S proteasome-associated PA28γ. Its recruitment to proteasome-containing complexes depends on PA28γ and its expression increases the association of PA28γ with the 20S proteasome in cells. Further dissection of its possible roles shows that PIP30 alters PA28γ-dependent activation of peptide degradation by the 20S proteasome in vitro and negatively controls in cells the presence of PA28γ in Cajal bodies by inhibition of its association with the key Cajal body component coilin. Taken together, our data show that PIP30 deeply affects PA28γ interactions with cellular proteins, including the 20S proteasome, demonstrating that it is an important regulator of PA28γ in cells and thus a new player in the control of the multiple functions of the proteasome within the nucleus.
- Published
- 2018
- Full Text
- View/download PDF
42. « Repose en paix » : pour le respect des droits des Anicinabek dans leurs rituels funéraires1
- Author
-
Marie-Pierre Bousquet
- Subjects
rituels funéraires ,death ,droits ,funeral rituals ,rights ,mort ,Anicinabek ,Algonquins ,General Medicine - Abstract
Cet article se penche sur les rites funéraires des Anicinabek (Algonquins) du Québec, en retraçant leur histoire jusqu’aux pratiques contemporaines. Il met l’accent sur les changements ayant contraint les Anicinabek à composer avec des règlements exogènes. De nos jours, si de nombreuses traditions persistent, la nécessité de se conformer à certaines normes fait parfois violence à leurs us et croyances. Nous relevons donc les questions qu’ils se posent face aux problèmes qu’ils rencontrent, ainsi que les adaptations qu’ils ont élaborées. Pour terminer, nous recommandons que les Amérindiens aient davantage accès aux informations concernant leurs droits ancestraux et que les intervenants des domaines entourant la mort soient sensibilisés pour un meilleur respect des personnes amérindiennes., This article examines the funerary rites of the Anicinabek (Algonquins) of Quebec, tracing back their history up to contemporary practices, and focuses on the changes that have forced the Anicinabek to deal with external rules. Today, while many traditions persist, the need to conform to certain norms can sometimes violate Anicinabek customs and beliefs. I describe the issues they face and the adaptations they have developed. By way of conclusion, I recommend that First Nations have greater access to information about their ancestral rights and that the stakeholders in the areas surrounding death be sensitized in order to be more respectful of Aboriginal people.
- Published
- 2018
- Full Text
- View/download PDF
43. Chapitre 8. La spiritualité amérindienne sur la place publique : à la recherche d'un statut
- Author
-
Marie-Pierre Bousquet
- Published
- 2018
- Full Text
- View/download PDF
44. Determination of differentially regulated proteins upon proteasome inhibition in AML cell lines by the combination of large-scale and targeted quantitative proteomics
- Author
-
Mariette Matondo, Bernard Monsarrat, Odile Burlet-Schiltz, Marlène Marcellin, Marie-Pierre Bousquet-Dubouch, Karima Chaoui, Anne Gonzalez-de-Peredo, Institut de pharmacologie et de biologie structurale (IPBS), Centre National de la Recherche Scientifique (CNRS)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées, The work was supported in part by grants from the Région Midi‐Pyrénées, the 'Fondation pour la Recherche Médicale' (programme Grands Equipements), European Fonds (FEDER), Toulouse metropole, 'Fond Social Européen' (FSE) and the 'Ligue contre le cancer' Grants., We thank Dr. Darragh O'Brien from Institut Pasteur for the careful reading of this manuscript., We thank members of the group for insightful comments related to this work. We would like to thank David Bouyssié for MFPAQ software and technical support. We would like also to thank our collaborators Stephane Manenti, for discussion. We Thanks Pr. Dr. Ruedi Aebersold from IMSB (ETH Zurich) for allowing the SRM measurement on the TSQ Vantage., Université Toulouse III - Paul Sabatier (UT3), and Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS)
- Subjects
0301 basic medicine ,MESH: Gene Ontology ,Technology ,Leupeptins ,Cellular differentiation ,Cell Cycle Proteins ,Apoptosis ,MESH: Cell Cycle / drug effects ,Biochemistry ,SILAC ,MESH: Interleukins / metabolism ,Bortezomib ,MESH: Leukocytes / drug effects ,Leukocytes ,MESH: Interleukins / genetics ,MESH: Apoptosis Regulatory Proteins / metabolism ,Protein Isoforms ,Proteasome inhibitor ,Phosphorylation ,MESH: Proteasome Endopeptidase Complex / drug effects ,Targeted proteomics ,Heat-Shock Proteins ,MESH: Proteasome Endopeptidase Complex / metabolism ,MESH: Computational Biology ,Chemistry ,Gene Expression Regulation, Leukemic ,Cell Cycle ,MESH: Apoptosis / drug effects ,Cell Differentiation ,Cell cycle ,MESH: Phosphorylation / drug effects ,MESH: Cell Cycle Proteins / metabolism ,3. Good health ,Cell biology ,MESH: Cell Cycle Proteins / genetics ,MESH: Heat-Shock Proteins / genetics ,Proteasome Inhibitors ,medicine.drug ,Research Article ,Signal Transduction ,MESH: Cell Differentiation ,Proteasome Endopeptidase Complex ,MESH: Cell Line, Tumor ,Quantitative proteomics ,MESH: Tumor Suppressor Protein p53 / metabolism ,MESH: Protein Isoforms / genetics ,MESH: Acetylcysteine / pharmacology ,MESH: Molecular Sequence Annotation ,MESH: Apoptosis Regulatory Proteins / genetics ,MESH: Transcription Factors / genetics ,MESH: Protein Isoforms / metabolism ,03 medical and health sciences ,MESH: Gene Expression Profiling ,MESH: Leukocytes / pathology ,Heat shock protein ,Cell Line, Tumor ,medicine ,MESH: Acetylcysteine / analogs & derivatives ,Humans ,[SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology ,Cell Cycle Protein ,Molecular Biology ,MESH: Proteasome Inhibitors / pharmacology ,MESH: Transcription Factors / metabolism ,MESH: Humans ,MESH: Leupeptins / pharmacology ,Gene Expression Profiling ,Interleukins ,Computational Biology ,Molecular Sequence Annotation ,MESH: Bortezomib / pharmacology ,MESH: Tumor Suppressor Protein p53 / genetics ,MESH: Heat-Shock Proteins / metabolism ,MESH: Leukocytes / metabolism ,Acetylcysteine ,030104 developmental biology ,Gene Ontology ,Proteasome ,MESH: Gene Expression Regulation, Leukemic / drug effects ,Tumor Suppressor Protein p53 ,Apoptosis Regulatory Proteins ,Human acute myeloid leukemia (AML) cells ,Transcription Factors - Abstract
International audience; The ubiquitin-proteasome pathway (UPP) plays a critical role in the degradation of proteins implicated in cell cycle control, signal transduction, DNA damage response, apoptosis and immune response. Proteasome inhibitors can inhibit the growth of a broad spectrum of human cancer cells by altering the balance of intracellular proteins. However, the targets of these compounds in acute myeloid leukemia (AML) cells have not been fully characterized. Herein, we combined large-scale quantitative analysis by SILAC-MS and targeted quantitative proteomic analysis in order to identify proteins regulated upon proteasome inhibition in two AML cell lines displaying different stages of maturation: immature KG1a cells and mature U937 cells. In-depth data analysis enabled accurate quantification of more than 7000 proteins in these two cell lines. Several candidates were validated by selected reaction monitoring (SRM) measurements in a large number of samples. Despite the broad range of proteins known to be affected by proteasome inhibition, such as heat shock (HSP) and cell cycle proteins, our analysis identified new differentially regulated proteins, including IL-32, MORF family mortality factors and apoptosis inducing factor SIVA, a target of p53. It could explain why proteasome inhibitors induce stronger apoptotic responses in immature AML cells.
- Published
- 2017
- Full Text
- View/download PDF
45. Comparison of label-free quantification methods for the determination of protein complexes subunits stoichiometry
- Author
-
Bernard Monsarrat, Odile Burlet-Schiltz, Thomas Menneteau, Marie-Pierre Bousquet-Dubouch, David Bouyssié, Bertrand Fabre, and Thomas Lambour
- Subjects
Chromatography ,Spectral counting ,lcsh:QH426-470 ,Chemistry ,Cellular pathways ,A protein ,Computational biology ,Biochemistry ,Molecular machine ,Affinity purification mass spectrometry (AP-MS) ,iBAQ ,Label-free quantification ,lcsh:Genetics ,Proteasome ,26S proteasome ,Stoichiometry ,Top3 - Abstract
Protein complexes are the main molecular machines that support all major cellular pathways and their in-depth characterization are essential to understand their functions. Determining the stoichiometry of the different subunits of a protein complex still remains challenging. Recently, many label-free quantitative proteomic approaches have been developed to study the composition of protein complexes. It is therefore of great interest to evaluate these different methods in a stoichiometry oriented objective. Here we compare the ability of four absolute quantitative label-free methods currently used in proteomic studies to determine the stoichiometry of a well-characterized protein complex, the 26S proteasome.
- Published
- 2014
46. Control of Paip1-Eukayrotic Translation Initiation Factor 3 Interaction by Amino Acids through S6 Kinase
- Author
-
Marie-Pierre Bousquet-Dubouch, David Shahbazian, Nahum Sonenberg, Tommy Alain, Yvan Martineau, Bertrand Fabre, Stéphane Pyronnet, Bernard Monsarrat, Emmanuel Petroulakis, and Xiaoshan Wang
- Subjects
Eukaryotic Initiation Factor-3 ,Biology ,Cell Line ,chemistry.chemical_compound ,Peptide Initiation Factors ,Cell Line, Tumor ,Eukaryotic initiation factor ,Humans ,Initiation factor ,Protein Interaction Domains and Motifs ,Amino Acids ,Phosphorylation ,Molecular Biology ,EIF4G ,TOR Serine-Threonine Kinases ,EIF4E ,RNA-Binding Proteins ,Ribosomal Protein S6 Kinases, 70-kDa ,Articles ,Cell Biology ,EIF4A1 ,Eukaryotic translation initiation factor 4 gamma ,Internal ribosome entry site ,EIF4EBP1 ,HEK293 Cells ,Biochemistry ,chemistry ,HeLa Cells ,Protein Binding ,Signal Transduction - Abstract
The simultaneous interaction of poly(A)-binding protein (PABP) with eukaryotic translation initiation factor 4G (eIF4G) and the mRNA 3' poly(A) tail promotes translation initiation. We previously showed that the interaction of PABP-interacting protein 1 (Paip1) with PABP and eukaryotic translation initiation factor 3 (eIF3; via the eIF3g subunit) further stimulates translation. Here, we demonstrate that the interaction of eIF3 with Paip1 is regulated by amino acids through the mTORC1 signaling pathway. The Paip1-eIF3 interaction is impaired by the mTORC1 inhibitors, rapamycin and PP242. We show that ribosomal protein S6 kinases 1 and 2 (S6K1/2) promote the interaction of eIF3 with Paip1. The enhancement of Paip1-eIF3 interaction by amino acids is abrogated by an S6K inhibitor or shRNA against S6K1/2. S6K1 interacts with eIF3f and, in vitro, phosphorylates eIF3. Finally, we show that S6K inhibition leads to a reduction in translation by Paip1. We propose that S6K1/2 phosphorylate eIF3 to stimulate Paip1-eIF3 interaction and consequent translation initiation. Taken together, these data demonstrate that eIF3 is a new translation target of the mTOR/S6K pathway.
- Published
- 2014
- Full Text
- View/download PDF
47. Aiamie1, agir au mieux ? Éthique, rituels catholiques et corps social chez les Anicinabek depuis les années 1950
- Author
-
Marie-Pierre Bousquet
- Subjects
General Medicine - Abstract
Cet article analyse la performance de rituels catholiques communautaires, comprenant des processions et des bénédictions, chez les Anicinabek (Algonquins). Il avance que leur étude donne à voir, dans le temps, l’éthique anicinabe. En effet, la période retenue, entre les années 1950 et 2000, correspond à des changements sociaux qui ont bouleversé l’ordre sociocosmique anicinabe. En portant attention à leur déroulement, à ce qu’ils mettent en scène du corps social, des relations avec le clergé et avec le surnaturel, nous postulons que ces rituels révèlent tant les transformations de l’imaginaire social et cosmologique anicinabe qu’un système de pensée pragmatique permettant de prendre les décisions pour se comporter, être et agir au mieux. Enfin, dans le contexte actuel où le catholicisme est en nette régression, nous examinons les nouveaux rites collectifs pour constater que ceux qui promeuvent les « bonnes manières de faire » tiennent essentiellement du domaine politique, terrain où se négocie maintenant la moralité commune., This article analyzes the performance of Catholic communal rituals, including processions and blessings, within the Anicinabek (Algonquin), which I argue, makes visible, over time, an Anicinabe ethics. The period studied, 1950 to 2000, corresponds to a time of social change that transformed the Anicinabe socio-cosmic order. In paying attention to the conduct of communal rituals, to what they depict of the social body, of relationships with clergy and with the supernatural, we see both changes in the Anicinabe social and cosmological imaginary, and a pragmatic system of thought that enables decision making about how to behave, to be and to act best. In the current context where Catholicism is in sharp decline, this paper examines the new collective rites and shows that those that promote « good ways of doing things » are mainly framed in the political arena, the space in which the common morality is now negotiated.
- Published
- 2013
- Full Text
- View/download PDF
48. Une ontologie anicinabe (algonquine) : discussions autour de l'expérience du bizarre
- Author
-
Marie-Pierre Bousquet
- Abstract
Cet article appartient a une demarche generale visant a decouvrir l’etre-au-monde des Anicinabek. Il privilegie l’etude de recits et de conduites relevant de l’experience de l’insolite. Il pose que la valeur de l’experience insolite comme modalite d’acquisition de la connaissance n’exclut aucunement la validite d’autres systemes explicatifs possibles pour les Anicinabek. Ainsi, il leur est tout a fait possible d’admettre a la fois la veracite des lois de la physique et de la biologie et des messages vehicules par les reves ou par d’autres truchements non reconnus par le rationalisme comme etant des bases d’une evidence. En reprenant les termes de Philippe Descola, on pourrait dire que les Anicinabek ont une ontologie qui permet de mettre en dialogue l’animisme et le naturalisme. En fait, l’ontologie anicinabe n’exclut dans son principe aucune categorie d’ontologies puisqu’elle est intrinsequement pragmatique. Afin de le montrer, cet article commence par replacer dans le cadre du systeme de pensee animiste le systeme explicatif mobilise pour apprehender les phenomenes bizarres et leur donner du sens. Il prend en compte les differentes allegeances religieuses presentes dans les communautes anicinabek. Puis, a la lumiere d’histoires d’experiences bizarres, il s’efforce de comprendre comment les Anicinabek evaluent les explications singulieres, en se penchant sur l’importance de l’experience personnelle.
- Published
- 2013
- Full Text
- View/download PDF
49. De la pensée holistique à l’Indian Time : dix stéréotypes à éviter sur les Amérindiens
- Author
-
Marie-Pierre Bousquet
- Subjects
Social Sciences and Humanities ,stereotypes ,Sense of community ,Quebec ,Gender studies ,Cognition ,General Medicine ,knowledge transfer ,Québec ,Amérindiens ,transfert de connaissances ,Spiritual life ,Sciences Humaines et Sociales ,stéréotypes ,Sociology ,intervention ,Native peoples - Abstract
This article is intended for practitioners working in Native communities, especially in Quebec. Building on the author’s experience as an anthropologist and her meetings with various practitioners, the paper proposes a reflection on ten stereotypes about Natives that have been heard most frequently, regarding : their way of thinking, their sense of community and of time, their relationship to nature, their spiritual life, their cognitive abilities and abilities to work, their codes of behaviour, their relationship to alcohol, and their needs. The author concludes by calling for better training of practitioners about Natives cultures., Cet article s’adresse aux intervenants travaillant dans les communautés amérindiennes, surtout du Québec. À partir de l’expérience de l’auteure, anthropologue, et de ses rencontres avec divers intervenants, l’article propose une réflexion sur dix stéréotypes sur les Amérindiens qu’elle a le plus fréquemment entendus : sur leur mode de pensée, leur sens de la communauté, leur conception du temps, leur rapport à la nature, leur vie spirituelle, leurs capacités cognitives et de travail, leurs codes de comportement, leur relation à l’alcool et leurs besoins. Enfin, elle prône une meilleure formation des intervenants sur les cultures autochtones.
- Published
- 2013
- Full Text
- View/download PDF
50. Subcellular Distribution and Dynamics of Active Proteasome Complexes Unraveled by a Workflow Combining in Vivo Complex Cross-Linking and Quantitative Proteomics
- Author
-
Bernard Monsarrat, Marie-Pierre Bousquet-Dubouch, Odile Burlet-Schiltz, Thomas Lambour, François Amalric, Julien Delobel, and Bertrand Fabre
- Subjects
Proteomics ,Proteasome Endopeptidase Complex ,Blotting, Western ,Quantitative proteomics ,Intracellular Space ,Plasma protein binding ,Protein degradation ,Biology ,Biochemistry ,Mass Spectrometry ,Substrate Specificity ,Analytical Chemistry ,Interferon-gamma ,Multienzyme Complexes ,Cell Line, Tumor ,Microsomes ,Humans ,Molecular Biology ,Leukemia ,Microscopy, Confocal ,Research ,Endoplasmic reticulum ,U937 Cells ,Cell biology ,Kinetics ,Protein Subunits ,Cross-Linking Reagents ,Proteasome ,Cell fractionation ,Intracellular ,Protein Binding - Abstract
Through protein degradation, the proteasome plays fundamental roles in different cell compartments. Although the composition of the 20S catalytic core particle (CP) has been well documented, little is known about the composition and dynamics of the regulatory complexes that play a crucial role in its activity, or about how they associate with the CP in different cell compartments, different cell lines, and in response to external stimuli. Because of difficulties performing acceptable cell fractionation while maintaining complex integrity, it has been challenging to characterize proteasome complexes by proteomic approaches. Here, we report an integrated protocol, combining a cross-linking procedure on intact cells with cell fractionation, proteasome immuno-purification, and robust label-free quantitative proteomic analysis by mass spectrometry to determine the distribution and dynamics of cellular proteasome complexes in leukemic cells. Activity profiles of proteasomes were correlated fully with the composition of protein complexes and stoichiometry. Moreover, our results suggest that, at the subcellular level, proteasome function is regulated by dynamic interactions between the 20S CP and its regulatory proteins—which modulate proteasome activity, stability, localization, or substrate uptake—rather than by profound changes in 20S CP composition. Proteasome plasticity was observed both in the 20S CP and in its network of interactions following IFNγ stimulation. The fractionation protocol also revealed specific proteolytic activities and structural features of low-abundance microsomal proteasomes from U937 and KG1a cells. These could be linked to their important roles in the endoplasmic reticulum associated degradation pathway in leukemic cells.
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.